Array (ARRY) 10-Q 8 Nov 22 2022 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2022	Nov. 07, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-39613
Entity Registrant Name	ARRAY TECHNOLOGIES, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	83-2747826
Entity Address, Address Line One	3901 Midway Place NE
Entity Address, City or Town	Albuquerque
Entity Address, State or Province	NM
Entity Address, Postal Zip Code	87109
City Area Code	(505)
Local Phone Number	881-7567
Title of 12(b) Security	Common stock, $0.001 par value
Trading Symbol	ARRY
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock Shares Outstanding		150,490,517
Entity Central Index Key	0001820721
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 62,778	$ 367,670
Accounts receivable, net	485,174	236,009
Inventories, net	269,775	205,653
Income tax receivables	12,765	9,052
Prepaid expenses and other	41,309	33,649
Total current assets	871,801	852,033
Property, plant and equipment, net	20,024	10,692
Goodwill	359,629	69,727
Other intangible assets, net	384,084	174,753
Deferred tax assets	18,785	9,345
Other assets	27,502	26,429
Total assets	1,681,825	1,142,979
Current liabilities
Accounts payable	199,358	91,392
Accounts payable - related party	478	610
Accrued expenses and other	91,102	38,494
Accrued warranty reserve	4,237	3,192
Income tax payable	10,587	60
Deferred revenue	154,692	99,575
Current portion of contingent consideration	0	1,773
Current portion of debt	47,686	4,300
Other current liabilities	4,981	5,909
Total current liabilities	513,121	245,305
Long-term liabilities
Deferred tax liability	74,139	0
Contingent consideration, net of current portion	7,113	12,804
Other long-term liabilities	9,113	5,557
Long-term warranty	3,852	0
Long-term debt, net of current portion	725,109	711,056
Total long-term liabilities	819,326	729,417
Total liabilities	1,332,447	974,722
Commitments and contingencies (Note 16)
Series A Redeemable Perpetual Preferred Stock of $0.001 par value - 500,000 authorized; 400,000 and 350,000 shares issued as of September 30, 2022 and December 31, 2021, respectively; liquidation preference of $400.0 million and $350.0 million as of September 30, 2022 and December 31, 2021, respectively	287,561	237,462
Stockholders’ equity (deficit)
Preferred stock of $0.001 par value - 4,500,000 shares authorized; none issued as of September 30, 2022 and December 31, 2021	0	0
Common stock of $0.001 par value - 1,000,000,000 shares authorized; 150,334,261 and 135,026,940 shares issued as of September 30, 2022 and December 31, 2021, respectively	150	135
Additional paid-in capital	392,862	202,562
Accumulated deficit	(258,360)	(271,902)
Accumulated other comprehensive income	(72,835)	0
Total stockholders’ equity (deficit)	61,817	(69,205)
Total liabilities, redeemable perpetual preferred stock and stockholders’ equity	$ 1,681,825	$ 1,142,979

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (unaudited) - (Parenthetical) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Temporary equity, par value (in dollars per share)	$ 0.001	$ 0.001
Authorized temporary equity stock (in shares)	500,000	500,000
Temporary equity, shares issued (in shares)	400,000	350,000
Temporary equity, liquidation preference	$ 400,000,000	$ 350,000,000
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Authorized preferred stock (in shares)	4,500,000	4,500,000
Preferred Stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Authorized common stock (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	150,334,261	135,026,940

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenue	$ 515,024	$ 188,686	$ 1,235,475	$ 633,442
Cost of revenue	434,801	182,789	1,088,719	560,872
Gross profit	80,223	5,897	146,756	72,570
Operating expenses
General and administrative	38,911	18,493	107,881	58,279
Contingent consideration	(572)	936	(5,981)	1,071
Depreciation and amortization	23,364	5,984	70,405	17,949
Total operating expenses	61,703	25,413	172,305	77,299
Income (loss) from operations	18,520	(19,516)	(25,549)	(4,729)
Other income (expense)
Other expense, net	(399)	(297)	(27)	(497)
Legal settlement	42,750	0	42,750	0
Foreign currency gain (loss)	(159)	0	1,968	0
Interest expense	(8,746)	(13,109)	(23,709)	(28,769)
Total other income (expense)	33,446	(13,406)	20,982	(29,266)
Income (loss) before income tax (benefit) expense	51,966	(32,922)	(4,567)	(33,995)
Income tax (benefit) expense	11,144	(5,361)	(18,109)	(5,493)
Net income (loss)	40,822	(27,561)	13,542	(28,502)
Preferred dividends and accretion	12,257	5,479	36,045	5,479
Net income (loss) to common shareholders	$ 28,565	$ (33,040)	$ (22,503)	$ (33,981)
Income (loss) per common share
Basic (in dollars per share)	$ 0.19	$ (0.25)	$ (0.15)	$ (0.26)
Diluted (in dollars per share)	$ 0.19	$ (0.25)	$ (0.15)	$ (0.26)
Weighted average number of common shares
Basic (in shares)	150,322	130,955	149,604	128,315
Diluted (in shares)	151,382	130,955	149,604	128,315

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 40,822	$ (27,561)	$ 13,542	$ (28,502)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Change in foreign currency translation adjustments	(34,106)	0	(72,835)	0
Comprehensive income (loss)	$ 6,716	$ (27,561)	$ (59,293)	$ (28,502)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders’ Equity (Deficit) (unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Series A Preferred Stock	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Series A Preferred Stock	Accumulated Deficit	Accumulated Other Comprehensive Loss
Temporary equity, beginning balance (in shares) at Dec. 31, 2020	0
Temporary equity, beginning balance at Dec. 31, 2020	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees (in shares)	350
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	$ 229,799
Preferred cumulative dividends plus accretion	$ 5,479
Temporary equity, ending balance (in shares) at Sep. 30, 2021	350
Temporary equity, ending balance at Sep. 30, 2021	$ 235,278
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2020			126,994
Stockholders' equity, beginning balance at Dec. 31, 2020	(80,899)		$ 127	$ 140,473		$ (221,499)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation	11,580			11,580
Issuance of stock, net (in shares)			7,875
Issuance of stock, net	104,764		$ 8	104,756
Preferred cumulative dividends plus accretion	(5,479)			(5,479)
Net income (loss)	(28,502)					(28,502)
Stockholders' equity, ending balance (in shares) at Sep. 30, 2021			134,869
Stockholders' equity, ending balance at Sep. 30, 2021	$ 1,464		$ 135	251,330		(250,001)
Temporary equity, beginning balance (in shares) at Jun. 30, 2021	0
Temporary equity, beginning balance at Jun. 30, 2021	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees (in shares)	350
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	$ 229,799
Preferred cumulative dividends plus accretion	$ 5,479
Temporary equity, ending balance (in shares) at Sep. 30, 2021	350
Temporary equity, ending balance at Sep. 30, 2021	$ 235,278
Stockholders' equity, beginning balance (in shares) at Jun. 30, 2021			126,994
Stockholders' equity, beginning balance at Jun. 30, 2021	(72,420)		$ 127	149,893		(222,440)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation	2,160			2,160
Issuance of stock, net (in shares)			7,875
Issuance of stock, net	104,764		$ 8	104,756
Preferred cumulative dividends plus accretion	(5,479)			(5,479)
Net income (loss)	(27,561)					(27,561)
Stockholders' equity, ending balance (in shares) at Sep. 30, 2021			134,869
Stockholders' equity, ending balance at Sep. 30, 2021	$ 1,464		$ 135	251,330		(250,001)
Temporary equity, beginning balance (in shares) at Dec. 31, 2021	350
Temporary equity, beginning balance at Dec. 31, 2021	$ 237,462
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees (in shares)	50
Issuance of Series A Redeemable Perpetual Preferred Stock, net of fees	$ 32,724
Preferred cumulative dividends plus accretion (in shares)	13
Preferred cumulative dividends plus accretion	$ 36,045
Dividends paid (in shares)	(13)
Dividends paid	$ (18,670)
Temporary equity, ending balance (in shares) at Sep. 30, 2022	400
Temporary equity, ending balance at Sep. 30, 2022	$ 287,561
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2021			135,026
Stockholders' equity, beginning balance at Dec. 31, 2021	(69,205)		$ 135	202,562		(271,902)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation (in shares)			161
Equity-based compensation	11,454			11,454
Issuance of stock, net (in shares)			15,147
Issuance of stock, net	216,078	$ (1,172)	$ 15	216,063	$ (1,172)
Preferred cumulative dividends plus accretion	(36,045)			(36,045)
Net income (loss)	13,542					13,542
Other comprehensive income (loss)	(72,835)						(72,835)
Stockholders' equity, ending balance (in shares) at Sep. 30, 2022			150,334
Stockholders' equity, ending balance at Sep. 30, 2022	$ 61,817		$ 150	392,862		(258,360)	(72,835)
Temporary equity, beginning balance (in shares) at Jun. 30, 2022	413
Temporary equity, beginning balance at Jun. 30, 2022	$ 293,974
Increase (Decrease) in Temporary Equity [Roll Forward]
Preferred cumulative dividends plus accretion	$ 12,257
Dividends paid (in shares)	(13)
Dividends paid	$ (18,670)
Temporary equity, ending balance (in shares) at Sep. 30, 2022	400
Temporary equity, ending balance at Sep. 30, 2022	$ 287,561
Stockholders' equity, beginning balance (in shares) at Jun. 30, 2022			150,279
Stockholders' equity, beginning balance at Jun. 30, 2022	63,853		$ 150	401,614		(299,182)	(38,729)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation (in shares)			55
Equity-based compensation	4,097			4,097
Issuance of stock, net		$ (592)			$ (592)
Preferred cumulative dividends plus accretion	(12,257)			(12,257)
Net income (loss)	40,822					40,822
Other comprehensive income (loss)	(34,106)						(34,106)
Stockholders' equity, ending balance (in shares) at Sep. 30, 2022			150,334
Stockholders' equity, ending balance at Sep. 30, 2022	$ 61,817		$ 150	$ 392,862		$ (258,360)	$ (72,835)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net income (loss)	$ 13,542	$ (28,502)
Adjustments to reconcile net income (loss) to net cash provided by, (used in) operating activities:
Provision for (recovery of) bad debts	660	(574)
Deferred tax expense	(30,928)	(7,036)
Depreciation and amortization	71,207	19,454
Amortization of debt discount and issuance costs	5,003	13,653
Equity-based compensation	11,677	11,706
Contingent consideration	(5,981)	1,071
Warranty provision	4,341	305
Provision for inventory obsolescence	(2,333)	654
Changes in operating assets and liabilities, net of business acquisition
Accounts receivable	(139,036)	(50,840)
Inventories	(14,273)	(55,321)
Income tax receivables	(3,610)	9,676
Prepaid expenses and other	11,146	(5,770)
Accounts payable	42,205	1,948
Accounts payable - related party	(132)	(1,622)
Accrued expenses and other	41,271	1,683
Warranty payments	(373)	0
Income tax payable	2,951	(8,185)
Lease liabilities	1,914	337
Deferred revenue	34,772	(68,474)
Net cash provided by, (used in) operating activities	44,023	(165,837)
Cash flows from investing activities
Purchase of property, plant and equipment	(6,690)	(2,252)
Acquisition of STI, net of cash acquired	(373,816)	0
Investment in equity security	0	(11,975)
Net cash used in investing activities	(380,506)	(14,227)
Cash flows from financing activities
Proceeds from Series A issuance	33,098	224,987
Proceeds from common stock issuance	15,885	120,645
Series A equity issuance costs	(1,167)	(7,195)
Common stock issuance costs	(450)	(3,873)
Dividends paid on Series A Preferred	(18,670)	0
Payments on revolving credit facility	(116,000)	(102,000)
Proceeds from issuance of other debt	39,219	0
Proceeds from revolving credit facility	116,000	102,000
Principal payments on debt	(33,286)	(132,150)
Contingent consideration	(1,483)	(7,810)
Debt issuance costs	0	(6,590)
Net cash provided by financing activities	33,146	188,014
Effect of exchange rate changes on cash and cash equivalent balances	(1,555)	0
Net change in cash and cash equivalents	(304,892)	7,950
Cash and cash equivalents, beginning of period	367,670	108,441
Cash and cash equivalents, end of period	62,778	116,391
Supplemental Cash Flow Information
Stock consideration paid for acquisition of STI	$ 200,224	$ 0

Organization and Business

Organization and Business	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Business	Organization and Business Array Technologies, Inc. (the “Company”), formerly ATI Intermediate Holdings, LLC, is a Delaware corporation formed in December 2018 as a wholly owned subsidiary of ATI Investment Parent, LLC (“Former Parent”). On October 14, 2020, the Company converted from a Delaware limited liability company to a Delaware corporation and changed the Company’s name to Array Technologies, Inc. The Company is headquartered in Albuquerque, New Mexico, and manufactures and supplies solar tracking systems and related products for customers across the United States and internationally. The Company, through its wholly-owned subsidiary, ATI Investment Sub, Inc. owns subsidiaries through which it conducts substantially all operations. Acquisition of STI On January 11, 2022 (the “Acquisition Date”), the Company acquired 100% of the share capital of Soluciones Técnicas Integrales Norland, S.L.U., a Spanish private limited liability Company, and its subsidiaries (collectively, “STI”) with cash and common stock of the Company (the “STI Acquisition”). The STI Acquisition was accounted for as a business combination. See Note 3 – Acquisition of STI .

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Accounting and Presentation The accompanying unaudited condensed consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). The unaudited interim financial statements have been prepared on the same basis as the audited annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of results for the interim periods reported. The results for the three and nine months ended September 30, 2022 are not necessarily indicative of results to be expected for the year ending December 31, 2022 or any other interim periods, or any future year or period. The balance sheet as of December 31, 2021 included herein was derived from the audited financial statements as of that date. Certain disclosures have been condensed or omitted from the interim financial statements. These financial statements should be read in conjunction with the Company’s audited financial statements included in the Company’s Annual Report on Form 10-K filed with the SEC on April 6, 2022, as amended by the Form 10-K/A filed with the SEC on April 6, 2022 (the “2021 Annual Report”). Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated upon consolidation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates include evaluation for any impairment of goodwill, impairment of long-lived assets, fair value of contingent consideration, Series A Redeemable Perpetual Preferred Stock and the related future tranche, allowance for credit losses, reserve for excess or obsolete inventories, valuation of deferred tax assets and warranty reserve. Actual results may differ from previously estimated amounts, and such differences may be material to the condensed consolidated financial statements; however, management believes that these estimates and assumptions provide a reasonable basis for the fair presentation of the consolidated financial statements. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the period they occur. Impact of COVID-19 Pandemic The Company continues to closely monitor the ongoing impact of the COVID-19 pandemic in all the locations where it operates. The Company’s priority remains the welfare of its employees. The Company expects persistent waves of COVID-19, including variants of the virus, to remain a headwind into the near future. The duration and extent to which it will continue to adversely impact the Company’s business and results of operations remain uncertain and could be material. The Company believes it has sufficient liquidity and financing options available and expects to have sufficient liquidity to operate for the next 12 months. The Company expects to use cash generated from operations and if needed, can access funds from the Revolving Credit Facility (as defined below). The Company also has $100 million in delayed draw ability under the Series A Redeemable Perpetual Preferred Stock (as defined below) future draw commitment; however, such a draw would increase the Company’s dividend obligations and outstanding common stock and failure to draw the delayed commitments will result in interest expense payable by the Company. See Note 13 – Redeemable Perpetual Preferred Stock . The Revolving Credit Facility has $166.6 million of availability. Impact of the Ongoing Conflict in Ukraine The ongoing conflict in Ukraine has reduced the availability of material that can be sourced in Europe and, as a result, increased logistics costs for the procurement of certain inputs and materials used in our products. We do not know ultimate severity or duration of the conflict in Ukraine, but we continue to monitor the situation and evaluate our procurement strategy and supply chain as to reduce any negative impact on our business, financial condition and results of operations. Inflation The Company could see an impact from elevated inflation and other operating costs. Interest rates have increased quickly and substantially as central banks in developed countries raise interest rates in an effort to subdue inflation, while government deficits and debt remain at high levels in many global markets. The eventual implications of higher government deficits and debt, tighter monetary policy, and potentially higher long-term interest rates may drive a higher cost of capital during our forecast period. Business Combinations The Company accounts for its business acquisitions under the acquisition method of accounting in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 805 Business Combinations (“ASC 805”). The excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill. Determining the fair value of assets acquired and liabilities assumed requires management’s judgment and often involves the use of significant estimates and assumptions, including assumptions with respect to future cash inflows and outflows, discount rates, asset lives, and market multiples, amongst other items. Foreign Currency Translation For non-U.S. subsidiaries that operate in a local currency environment, assets and liabilities are translated into the U.S. dollar at period end exchange rates. Income, expense and cash flow items are translated at average exchange rates prevailing during the period. Translation adjustments for these subsidiaries are accumulated as a separate component of accumulated other comprehensive income in equity. For non-U.S. subsidiaries that use a U.S. dollar functional currency, local currency inventories and property, plant and equipment are translated into U.S. dollars at rates prevailing when acquired, and all other assets and liabilities are translated at period end exchange rates. Inventories charged to cost of revenue and depreciation are remeasured at historical rates, and all other income and expense items are translated at average exchange rates prevailing during the period. Gains and losses which result from remeasurement are included in earnings. Recent Accounting Pronouncements Adopted In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ ASU 2021-08”). ASU 2021-08 requires the company acquiring contract assets and contract liabilities obtained in a business combination to recognize and measure them in accordance with ASC Topic 606, Revenue from Contracts with Customers (“ ASC 606”). At the acquisition date, the company acquiring the business should record related revenue, as if it had originated the contract. Before the recent update, such amounts were recognized by the acquiring company at fair value. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted, including in interim periods, for any financial statements that have not yet been issued. The Company early adopted ASU 2021-08 as of January 1, 2022. See Note 3 – Acquisition of STI for further information and disclosures related to the STI Acquisition. The standard was applied to the acquisition accounting for STI. A review of the deferred revenue of the acquiree of $20.3 million was reviewed for consistency in application with the Company’s policies and U.S. GAAP and the contract liability balance was carried over at its carrying value.

Acquisition of STI

Acquisition of STI	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Acquisition of STI	Acquisition of STI On the Acquisition Date, the Company completed the STI Acquisition pursuant to the purchase agreement, dated November 10, 2021, by and among Amixa Capital, S.L. and Aurica Trackers, S.L., each a company duly organized under the laws of the Kingdom of Spain (together, the “Sellers”) and Mr. Javier Reclusa Etayo (the “STI Purchase Agreement”). The STI Acquisition was funded primarily with borrowings from the Convertible Notes (as defined below) and the issuance of Series A redeemable perpetual preferred stock of the Company, par value $0.001 per share (the “Series A Redeemable Perpetual Preferred Stock”). The STI Acquisition provided the Company with an immediate presence in Brazil, Western Europe and South Africa. Transaction expenses incurred in connection with the acquisition are $5.6 million recorded in the general and administrative line item on the condensed consolidated statement of operations for the nine months ended September 30, 2022. In accordance with the STI Purchase Agreement, the Company paid closing consideration to the Sellers consisting of $410.5 million in cash and 13,894,800 shares of the Company’s common stock. The fair value of the purchase consideration was $610.8 million and resulted in the Company owning 100% of the interests in STI. The Company has performed a valuation of the acquisition assets and liabilities and determined the related accounting impact. The purchase price consideration to acquire STI consisted of the following (in thousands): Cash consideration for STI $ 409,647 Cash consideration for transaction expenses of STI 896 Total cash consideration 410,543 Non-cash equity consideration 200,224 Total consideration transferred 610,767 Total purchase price consideration $ 610,767 The STI Acquisition was accounted for as a business combination applying ASC 805. The equity consideration transferred consisted of the Company’s common stock and was measured at fair value based on the closing stock price on the Acquisition Date. The purchase price was allocated to the assets acquired and liabilities assumed based on management’s estimate of the respective fair values at the Acquisition Date. Goodwill was calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. The factors contributing to the recognition of goodwill were the expected synergies of the combined entities that are expected to be realized from the STI Acquisition. None of the goodwill is expected to be deductible for income tax purposes. The following table summarizes the preliminary estimates of fair values of the assets acquired and liabilities assumed as of the Acquisition Date (in thousands): Preliminary Fair Value of Net Assets Acquired and Liabilities Assumed: Acquisition Date Measurement Adjustment September 30, 2022 Cash and cash equivalents $ 36,725 $ — $ 36,725 Accounts receivable 110,789 — 110,789 Inventories 47,517 — 47,517 Prepaid expenses and other 23,399 — 23,399 Property, plant and equipment 4,434 — 4,434 Other intangible assets 318,365 — 318,365 Other assets 325 — 325 Total assets acquired $ 541,554 $ — $ 541,554 Accounts payable 65,761 — 65,761 Deferred revenue 20,345 — 20,345 Short-term debt 44,338 — 44,338 Other liabilities 10,115 — 10,115 Income tax payable 7,576 — 7,576 Deferred tax liability 93,823 7,611 101,434 Other long-term liabilities 4,524 — 4,524 Long-term debt 12,053 — 12,053 Total liabilities assumed $ 258,535 $ 7,611 $ 266,146 Preliminary fair value of net assets acquired 283,019 275,408 Preliminary allocation to goodwill $ 327,748 $ 335,359 The preliminary purchase price allocation was based upon a preliminary valuation, and the Company’s estimates and assumptions are subject to change within the measurement period (defined as the twelve months following the Acquisition Date). The preliminary estimates of the fair values of the assets acquired and liabilities assumed were estimated to approximate carrying values since they are short term in nature, and they are receivable or payable on demand. These assets and liabilities were cash and cash equivalents, accounts receivable, prepaid expenses and other, accounts payable, other liabilities, and deferred revenue. The primary areas of the preliminary purchase price allocation that are not yet finalized relate to the valuation of identifiable intangible assets acquired, the fair value of certain tangible assets acquired and liabilities assumed as well as the tax impact. The Company expects to continue to obtain information for the purpose of determining the fair value of the assets acquired and liabilities assumed on the Acquisition Date throughout the remainder of the measurement period. The purchase price allocation is subject to further adjustment until all pertinent information regarding the assets acquired is fully evaluated by the Company, including but not limited to, the fair value accounting. For assets and liabilities excluded from the scope of the intangible asset and property, plant and equipment valuation, the Company considered net book value to be a reasonable proxy as of the Acquisition Date. The preliminary purchase price allocation includes $318.4 million of acquired identifiable intangible assets. Estimated Fair Value Estimated Weighted Average Useful Life in Years (in thousands, except useful lives) Backlog $ 51,165 1 Customer relationships 238,770 10 Trade name 28,430 20 Total $ 318,365 The preliminary fair value of the identifiable intangible assets has been estimated using the Excess Earnings Method (customer relationships and backlog) and Relief from Royalty Method (trade name). Significant inputs using the Excess Earnings Method and Level 3 inputs in the fair value hierarchy include estimated revenue, expenses based on actuals and forecast, and a discount rate based on a weighted average cost of capital for customer relationships of 15% for Spain, 16.5% for Brazil and 14.0% for Spain foreign sourced projects and for order backlog of 8.5% for Spain, 9.5% for Brazil and 7.5% for Spain foreign sourced projects. Significant inputs to the Relief from Royalty method model include estimates of future revenue, economic life, estimated royalty rate of 1.25%, and a discount rate based on a weighted average cost of capital 15.2%. The weighted average cost of capital was determined based on the Company’s capital structure, cost of capital, inherent business risk profile and long-term growth expectations. The intangible assets are being amortized over their estimated useful lives on a straight-line basis that reflects the economic benefit of the asset. The determination of the useful lives is based upon various industry studies, historical acquisition experience, economic factors, and future forecasted cash flows of the Company following the STI Acquisition. The amounts of revenue and net loss of STI included in the Company’s consolidated statement of operations from the Acquisition Date through September 30, 2022 are $237.2 million and $14.1 million, respectively. Pro Forma Financial Information (Unaudited) The following unaudited pro forma financial information presents the combined results of operations of the Company and STI as if the acquisition had occurred on January 1, 2021, after giving effect to certain unaudited pro forma adjustments. The unaudited pro forma adjustments reflected herein include only those adjustments that are directly attributable to the STI Acquisition including amortization of intangibles, debt financing expenses and tax benefits. The unaudited pro forma financial information does not reflect any adjustments for anticipated expense savings resulting from the STI Acquisition and is not necessarily indicative of the operating results that would have actually occurred had the STI Acquisition been consummated on January 1, 2021. Three Months Ended Nine Months Ended (in millions) 2022 2021 2022 2021 Revenue $ 515.0 $ 480.1 $ 1,243.0 $ 764.8 Net income (loss) $ 52.1 $ (22.7) $ 48.7 $ (44.6)

Accounts Receivable

Accounts Receivable	9 Months Ended
	Sep. 30, 2022
Receivables [Abstract]
Accounts Receivable	Accounts Receivable Accounts receivable consists of the following (in thousands): September 30, 2022 December 31, 2021 Accounts receivable $ 485,869 $ 236,149 Less: allowance for doubtful accounts (695) (140) Accounts receivable, net $ 485,174 $ 236,009

Inventories

Inventories	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories consist of the following (in thousands): September 30, 2022 December 31, 2021 Raw materials $ 166,260 $ 85,470 Finished goods 108,597 127,598 Reserve for excess or obsolete inventory (5,082) (7,415) Total $ 269,775 $ 205,653

Property, Plant, and Equipment

Property, Plant, and Equipment	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment consisted of the following (in thousands, except useful lives): Estimated Useful Lives (Years) September 30, 2022 December 31, 2021 Land N/A $ 1,563 $ 1,340 Buildings and land improvements 15-39 7,318 2,451 Manufacturing equipment 7 17,893 13,924 Furniture, fixtures and equipment 5-7 3,341 476 Vehicles 5 527 161 Hardware and software 3-5 2,487 1,683 Assets in progress 3,684 1,880 Total 36,813 21,915 Less: accumulated depreciation (16,789) (11,223) Property, plant and equipment, net $ 20,024 $ 10,692 Depreciation expense was $0.7 million and $0.6 million for the three months ended September 30, 2022 and 2021, respectively, of which $0.4 million and $0.5 million, respectively, was allocated to cost of revenue and $0.3 million and $0.1 million, respectively, was included in depreciation and amortization in the accompanying condensed consolidated statements of operations for the three months ended September 30, 2022 and 2021.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill Prior to the STI Acquisition, goodwill, related to Former Parent’s acquisition of the Company, was recorded as $121.6 million and was subsequently impaired. Total accumulated impairment as of September 30, 2022 was $51.9 million. The Company recorded an additional $335.4 million of goodwill as a result of the STI Acquisition and the Company’s reporting units became Array Legacy Operations and the newly acquired STI Operations, which had goodwill of $69.7 million and $289.9 million, respectively, at September 30, 2022 and $69.7 million and zero, respectively, at December 31, 2021. Goodwill is not deductible for tax purposes. Changes in the carrying amount of goodwill by operating segment during the nine months ended September 30, 2022 are shown below (in thousands): Array Legacy Operations Segment STI Operations Segment Total Beginning Balance $ 69,727 $ — $ 69,727 Acquisition of STI — 335,359 $ 335,359 Foreign currency impact — (45,457) $ (45,457) Ending Balance $ 69,727 $ 289,902 $ 359,629 Each quarter the Company evaluates if facts and circumstances indicate that it is more-likely-than-not that the fair value of its reporting units is less than their carrying value, which would require the Company to perform an interim goodwill impairment test. During the quarter ended March 31, 2022, the Company determined it was necessary to perform an interim goodwill impairment test for the Array Legacy Operations reporting unit. The Company performed a quantitative goodwill impairment test and determined the estimated fair value of the reporting unit exceeded the carrying value assigned to that reporting unit; as a result, goodwill was not impaired. Other Intangible Assets Other intangible assets consisted of the following (in thousands, except useful lives): Estimated Useful Lives (Years) September 30, 2022 December 31, 2021 Amortizable: Costs: Developed technology 14 $ 203,800 $ 203,800 Customer relationships 10 295,405 89,500 Backlog 1 44,132 — Trade name 20 24,518 — Total amortizable intangibles 567,855 293,300 Accumulated amortization: Developed technology 90,709 79,790 Customer relationships 70,606 49,057 Backlog 31,794 — Trade name 962 — Total accumulated amortization 194,071 128,847 Total amortizable intangibles, net 373,784 164,453 Non-amortizable costs: Trade name 10,300 10,300 Total other intangible assets, net $ 384,084 $ 174,753 Amortization expense related to intangible assets amounted to $23.2 million and $5.9 million for the three months ended September 30, 2022 and 2021, respectively, and $69.8 million and $17.6 million for the nine months ended September 30, 2022 and 2021, respectively. Estimated future annual amortization expense for the above amortizable intangible assets for the remaining periods through September 30, as follows (in thousands): Amount 2022 $ 22,365 2023 46,633 2024 45,328 2025 45,328 2026 41,021 Thereafter 173,109 $ 373,784 Long-lived assets, including intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. During the quarter ended March 31, 2022, the Company determined it was necessary to review long-lived assets, including intangible assets related to the Array Legacy Operations reporting unit, for impairment. The Company determined the undiscounted cash flows expected to result from the use of the asset group and its eventual disposition were greater than the carrying amount and therefore concluded there was no impairment.

Investment in Equity Security

Investment in Equity Security	9 Months Ended
	Sep. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Investment in Equity Security	Investment in Equity Security The Company made a $10.0 million and $2.0 million investment in preferred stock of a private company in February 2021 and April 2021, respectively. The investment is accounted for in accordance with ASC Topic 321 Investments—Equity Securities at its cost, less any impairment. The investment balance as of September 30, 2022 was $12.0 million and is recorded in other assets on the condensed consolidated balance sheets. There is no impairment recorded for the nine months ended September 30, 2022.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company follows guidance under ASC Topic 740-270 Income Taxes , which requires that an estimated annual effective tax rate is applied to year-to-date ordinary income (loss). At the end of each interim period, the Company estimates the effective tax rate expected to be applicable for the full fiscal year. The tax effect of discrete items is recorded in the quarter in which the discrete events occur. The Company recorded income tax expense (benefit) of $11.1 million and $(5.4) million for the three months ended September 30, 2022 and 2021, respectively, and income tax expense (benefit) of $(18.1) million and $5.5 million for the nine months ended September 30, 2022 and 2021, respectively. The tax expense in the three months ended September 30, 2022 includes tax expense of $8.7 million on the legal settlement income which was recorded discretely in the quarter. The tax, excluding the legal settlement, was favorably impacted by non-taxable contingent income, and mix of income by jurisdiction. The tax benefit in the three months ended September 30, 2021 was unfavorably impacted by non-deductible amounts for equity-based compensation and follow-on offering costs. The tax benefit in the nine months ended September 30, 2022 includes tax expense of $8.7 million on the legal settlement which was recorded discretely in the quarter. The tax on the loss, excluding the legal settlement, was favorably impacted by mix of earnings by jurisdictions offset by non-deductible amounts for officers’ compensation and transaction costs. The tax benefit in the nine months ended September 30, 2021 was unfavorably impacted by non-deductible equity based compensation as well as initial public offering and secondary offering costs. For the three and nine months ended September 30, 2022 and 2021, no reserves for uncertain tax positions have been recorded. The Company will continue to monitor this position each interim period. In August 2022, the U.S. Inflation Reduction Act (“IRA”) was enacted into law. The IRA contains a number of revisions to the Internal Revenue Code that generally take effect in tax years beginning after December 31, 2022. The Company is in the process of evaluating provisions included under the IRA and its impact to the Company’s consolidated financial statements.

Senior Secured Credit Facility

Senior Secured Credit Facility	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Senior Secured Credit Facility	Senior Secured Credit Facility Long-term senior secured credit facility consisted of the following (in thousands): September 30, 2022 December 31, 2021 Term loan facility $ 323,550 $ 326,775 Revolving credit facility — — 323,550 326,775 Less discount and issuance costs (20,169) (23,291) Long-term portion, net of debt discount and issuance costs 303,381 303,484 Less current portion of credit facility (4,300) (4,300) Long-term senior secured facility debt, net of current portion, debt discount and issuance costs $ 299,081 $ 299,184 Senior Secured Credit Facility On October 14, 2020, the Company entered into a senior secured credit facility, which was amended on February 23, 2021 (the “First Amendment”) and again on February 26, 2021 (the “Second Amendment”). The senior secured facility consisted originally of (i) a $575 million senior secured 7-year term loan facility (the “Term Loan Facility”) and (ii) a $150 million senior secured 5-year revolving credit facility (the “Revolving Credit Facility” and, together with the Term Loan Facility, the “Senior Secured Credit Facility”). The First Amendment, in the case of Eurocurrency borrowings, lowered the London interbank offered rate floor to 50 basis points from 100 basis points and lowered the applicable margin to 325 basis points from 400 basis points per annum. This resulted in the current rate on the Term Loan Facility decreasing to 3.75% down from 5% prior to the First Amendment. The Second Amendment increased the $150.0 million Revolving Credit Facility from $150.0 million to $200.0 million. Revolving Credit Facility Under the Revolving Credit Facility, the Company had no outstanding balance as of both September 30, 2022 and December 31, 2021, respectively, $33.4 million and $13.6 million in standby letters of credit at September 30, 2022 and December 31, 2021, respectively, and availability of $166.6 million and $186.4 million at September 30, 2022 and December 31, 2021, respectively. The Revolving Credit Facility pays interest depending on the contracted rate for the loan which is either for the Eurocurrency Rate Loans at LIBOR plus 3.25% and for Base Rate Loans at the higher of the Prime Rate, 1/2 of 1% above the Federal Funds Rate or the Eurocurrency rate for the Dollar deposits for one month interest period, after giving effect to any floor plus 1%, plus 2.25%. Term Loan Facility The Term Loan Facility had a balance of $323.6 million and $326.8 million as of September 30, 2022 and December 31, 2021, respectively. The balance of the Term Loan Facility is presented in the accompanying condensed consolidated balance sheets, net of debt discount and issuance costs of $20.2 million and $23.3 million as of September 30, 2022 and December 31, 2021, respectively. The debt discount and issuance costs are being amortized using the effective interest method and the rate as of September 30, 2022 is 6.75%. The Term Loan Facility has an annual excess cash flow calculation, for which the prescribed formula did not result in requiring the Company to make an advance principal payment for the year ended December 31, 2021. Convertible debt consisted of the following (in thousands): September 30, 2022 December 31, 2021 1.00% Senior unsecured convertible notes $ 425,000 $ 425,000 Less: unamortized discount and issuance costs (11,721) (13,137) 1.00% Senior unsecured convertible notes, net (1) $ 413,279 $ 411,863 (1) Effective interest rate for the Convertible Notes as of September 30, 2022 and December 31, 2021 was 1.5%. On December 3, 2021 and December 9, 2021, the Company completed a private offering of $375 million and $50 million over allotment, respectively, in aggregate principal amount of 1.00% Convertible Senior Notes due 2028 (the “Convertible Notes”), resulting in proceeds of $364.7 million and $48.6 million, respectively, after deducting the original issue discount of 2.75%. The Convertible Notes were issued pursuant to an indenture, dated December 3, 2021, between the Company and U.S. Bank National Association, as trustee. The Convertible Notes are senior unsecured obligations of the Company and will mature on December 1, 2028, unless earlier converted, redeemed, or repurchased. The Convertible Notes bear interest at a rate of 1.00% per year, payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2022. The conversion rate for the Notes was initially 41.9054 shares of the Company’s common stock per $1,000 principal amount of Notes, which was equivalent to an initial conversion price of approximately $23.86 per share of common stock or 10.1 million shares of common stock. The Convertible Notes were not convertible during the nine months ended September 30, 2022 and none have been converted to date. Also, given that the average market price of the Company’s common stock has not exceeded the exercise price since inception, there was no dilutive impact for the nine months ended September 30, 2022. Capped Calls In connection with the issuances of the Convertible Notes, the Company paid $52.9 million, in aggregate, to enter into capped call option agreements to reduce the potential dilution to holders of the Company’s common stock after a conversion of the Convertible Notes. Specifically, upon the exercise of the capped call instruments issued pursuant to the agreements (the “Capped Calls”), the Company would receive shares of its common stock equal to approximately 17.8 million shares (a) multiplied by (i) the lower of $36.0200 or the then-current market price of its common stock, less (ii) the applicable exercise price, $23.86, and (b) divided by the then-current market price of its common stock. The results of this formula are that the Company would receive more shares as the market price of its common stock exceeds the exercise price and approaches the cap, which was initially $36.0200 per share. Consequently, if the Convertible Notes are converted, then the number of shares to be issued by the Company would be effectively partially offset by the shares of common stock received by the Company under the Capped Calls as they are exercised. The formula above would be adjusted in the event of certain specified extraordinary events affecting the Company, including a merger; a tender offer; nationalization, insolvency or delisting of the Company’s common stock; changes in law; failure to deliver; insolvency filing; stock splits, combinations, dividends, repurchases or similar events; or an announcement of certain of the preceding actions.

Convertible Debt

Convertible Debt	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Convertible Debt	Senior Secured Credit Facility Long-term senior secured credit facility consisted of the following (in thousands): September 30, 2022 December 31, 2021 Term loan facility $ 323,550 $ 326,775 Revolving credit facility — — 323,550 326,775 Less discount and issuance costs (20,169) (23,291) Long-term portion, net of debt discount and issuance costs 303,381 303,484 Less current portion of credit facility (4,300) (4,300) Long-term senior secured facility debt, net of current portion, debt discount and issuance costs $ 299,081 $ 299,184 Senior Secured Credit Facility On October 14, 2020, the Company entered into a senior secured credit facility, which was amended on February 23, 2021 (the “First Amendment”) and again on February 26, 2021 (the “Second Amendment”). The senior secured facility consisted originally of (i) a $575 million senior secured 7-year term loan facility (the “Term Loan Facility”) and (ii) a $150 million senior secured 5-year revolving credit facility (the “Revolving Credit Facility” and, together with the Term Loan Facility, the “Senior Secured Credit Facility”). The First Amendment, in the case of Eurocurrency borrowings, lowered the London interbank offered rate floor to 50 basis points from 100 basis points and lowered the applicable margin to 325 basis points from 400 basis points per annum. This resulted in the current rate on the Term Loan Facility decreasing to 3.75% down from 5% prior to the First Amendment. The Second Amendment increased the $150.0 million Revolving Credit Facility from $150.0 million to $200.0 million. Revolving Credit Facility Under the Revolving Credit Facility, the Company had no outstanding balance as of both September 30, 2022 and December 31, 2021, respectively, $33.4 million and $13.6 million in standby letters of credit at September 30, 2022 and December 31, 2021, respectively, and availability of $166.6 million and $186.4 million at September 30, 2022 and December 31, 2021, respectively. The Revolving Credit Facility pays interest depending on the contracted rate for the loan which is either for the Eurocurrency Rate Loans at LIBOR plus 3.25% and for Base Rate Loans at the higher of the Prime Rate, 1/2 of 1% above the Federal Funds Rate or the Eurocurrency rate for the Dollar deposits for one month interest period, after giving effect to any floor plus 1%, plus 2.25%. Term Loan Facility The Term Loan Facility had a balance of $323.6 million and $326.8 million as of September 30, 2022 and December 31, 2021, respectively. The balance of the Term Loan Facility is presented in the accompanying condensed consolidated balance sheets, net of debt discount and issuance costs of $20.2 million and $23.3 million as of September 30, 2022 and December 31, 2021, respectively. The debt discount and issuance costs are being amortized using the effective interest method and the rate as of September 30, 2022 is 6.75%. The Term Loan Facility has an annual excess cash flow calculation, for which the prescribed formula did not result in requiring the Company to make an advance principal payment for the year ended December 31, 2021. Convertible debt consisted of the following (in thousands): September 30, 2022 December 31, 2021 1.00% Senior unsecured convertible notes $ 425,000 $ 425,000 Less: unamortized discount and issuance costs (11,721) (13,137) 1.00% Senior unsecured convertible notes, net (1) $ 413,279 $ 411,863 (1) Effective interest rate for the Convertible Notes as of September 30, 2022 and December 31, 2021 was 1.5%. On December 3, 2021 and December 9, 2021, the Company completed a private offering of $375 million and $50 million over allotment, respectively, in aggregate principal amount of 1.00% Convertible Senior Notes due 2028 (the “Convertible Notes”), resulting in proceeds of $364.7 million and $48.6 million, respectively, after deducting the original issue discount of 2.75%. The Convertible Notes were issued pursuant to an indenture, dated December 3, 2021, between the Company and U.S. Bank National Association, as trustee. The Convertible Notes are senior unsecured obligations of the Company and will mature on December 1, 2028, unless earlier converted, redeemed, or repurchased. The Convertible Notes bear interest at a rate of 1.00% per year, payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2022. The conversion rate for the Notes was initially 41.9054 shares of the Company’s common stock per $1,000 principal amount of Notes, which was equivalent to an initial conversion price of approximately $23.86 per share of common stock or 10.1 million shares of common stock. The Convertible Notes were not convertible during the nine months ended September 30, 2022 and none have been converted to date. Also, given that the average market price of the Company’s common stock has not exceeded the exercise price since inception, there was no dilutive impact for the nine months ended September 30, 2022. Capped Calls In connection with the issuances of the Convertible Notes, the Company paid $52.9 million, in aggregate, to enter into capped call option agreements to reduce the potential dilution to holders of the Company’s common stock after a conversion of the Convertible Notes. Specifically, upon the exercise of the capped call instruments issued pursuant to the agreements (the “Capped Calls”), the Company would receive shares of its common stock equal to approximately 17.8 million shares (a) multiplied by (i) the lower of $36.0200 or the then-current market price of its common stock, less (ii) the applicable exercise price, $23.86, and (b) divided by the then-current market price of its common stock. The results of this formula are that the Company would receive more shares as the market price of its common stock exceeds the exercise price and approaches the cap, which was initially $36.0200 per share. Consequently, if the Convertible Notes are converted, then the number of shares to be issued by the Company would be effectively partially offset by the shares of common stock received by the Company under the Capped Calls as they are exercised. The formula above would be adjusted in the event of certain specified extraordinary events affecting the Company, including a merger; a tender offer; nationalization, insolvency or delisting of the Company’s common stock; changes in law; failure to deliver; insolvency filing; stock splits, combinations, dividends, repurchases or similar events; or an announcement of certain of the preceding actions.

Other Debt

Other Debt	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Other Debt	Senior Secured Credit Facility Long-term senior secured credit facility consisted of the following (in thousands): September 30, 2022 December 31, 2021 Term loan facility $ 323,550 $ 326,775 Revolving credit facility — — 323,550 326,775 Less discount and issuance costs (20,169) (23,291) Long-term portion, net of debt discount and issuance costs 303,381 303,484 Less current portion of credit facility (4,300) (4,300) Long-term senior secured facility debt, net of current portion, debt discount and issuance costs $ 299,081 $ 299,184 Senior Secured Credit Facility On October 14, 2020, the Company entered into a senior secured credit facility, which was amended on February 23, 2021 (the “First Amendment”) and again on February 26, 2021 (the “Second Amendment”). The senior secured facility consisted originally of (i) a $575 million senior secured 7-year term loan facility (the “Term Loan Facility”) and (ii) a $150 million senior secured 5-year revolving credit facility (the “Revolving Credit Facility” and, together with the Term Loan Facility, the “Senior Secured Credit Facility”). The First Amendment, in the case of Eurocurrency borrowings, lowered the London interbank offered rate floor to 50 basis points from 100 basis points and lowered the applicable margin to 325 basis points from 400 basis points per annum. This resulted in the current rate on the Term Loan Facility decreasing to 3.75% down from 5% prior to the First Amendment. The Second Amendment increased the $150.0 million Revolving Credit Facility from $150.0 million to $200.0 million. Revolving Credit Facility Under the Revolving Credit Facility, the Company had no outstanding balance as of both September 30, 2022 and December 31, 2021, respectively, $33.4 million and $13.6 million in standby letters of credit at September 30, 2022 and December 31, 2021, respectively, and availability of $166.6 million and $186.4 million at September 30, 2022 and December 31, 2021, respectively. The Revolving Credit Facility pays interest depending on the contracted rate for the loan which is either for the Eurocurrency Rate Loans at LIBOR plus 3.25% and for Base Rate Loans at the higher of the Prime Rate, 1/2 of 1% above the Federal Funds Rate or the Eurocurrency rate for the Dollar deposits for one month interest period, after giving effect to any floor plus 1%, plus 2.25%. Term Loan Facility The Term Loan Facility had a balance of $323.6 million and $326.8 million as of September 30, 2022 and December 31, 2021, respectively. The balance of the Term Loan Facility is presented in the accompanying condensed consolidated balance sheets, net of debt discount and issuance costs of $20.2 million and $23.3 million as of September 30, 2022 and December 31, 2021, respectively. The debt discount and issuance costs are being amortized using the effective interest method and the rate as of September 30, 2022 is 6.75%. The Term Loan Facility has an annual excess cash flow calculation, for which the prescribed formula did not result in requiring the Company to make an advance principal payment for the year ended December 31, 2021. Convertible debt consisted of the following (in thousands): September 30, 2022 December 31, 2021 1.00% Senior unsecured convertible notes $ 425,000 $ 425,000 Less: unamortized discount and issuance costs (11,721) (13,137) 1.00% Senior unsecured convertible notes, net (1) $ 413,279 $ 411,863 (1) Effective interest rate for the Convertible Notes as of September 30, 2022 and December 31, 2021 was 1.5%. On December 3, 2021 and December 9, 2021, the Company completed a private offering of $375 million and $50 million over allotment, respectively, in aggregate principal amount of 1.00% Convertible Senior Notes due 2028 (the “Convertible Notes”), resulting in proceeds of $364.7 million and $48.6 million, respectively, after deducting the original issue discount of 2.75%. The Convertible Notes were issued pursuant to an indenture, dated December 3, 2021, between the Company and U.S. Bank National Association, as trustee. The Convertible Notes are senior unsecured obligations of the Company and will mature on December 1, 2028, unless earlier converted, redeemed, or repurchased. The Convertible Notes bear interest at a rate of 1.00% per year, payable semiannually in arrears on June 1 and December 1 of each year, beginning on June 1, 2022. The conversion rate for the Notes was initially 41.9054 shares of the Company’s common stock per $1,000 principal amount of Notes, which was equivalent to an initial conversion price of approximately $23.86 per share of common stock or 10.1 million shares of common stock. The Convertible Notes were not convertible during the nine months ended September 30, 2022 and none have been converted to date. Also, given that the average market price of the Company’s common stock has not exceeded the exercise price since inception, there was no dilutive impact for the nine months ended September 30, 2022. Capped Calls In connection with the issuances of the Convertible Notes, the Company paid $52.9 million, in aggregate, to enter into capped call option agreements to reduce the potential dilution to holders of the Company’s common stock after a conversion of the Convertible Notes. Specifically, upon the exercise of the capped call instruments issued pursuant to the agreements (the “Capped Calls”), the Company would receive shares of its common stock equal to approximately 17.8 million shares (a) multiplied by (i) the lower of $36.0200 or the then-current market price of its common stock, less (ii) the applicable exercise price, $23.86, and (b) divided by the then-current market price of its common stock. The results of this formula are that the Company would receive more shares as the market price of its common stock exceeds the exercise price and approaches the cap, which was initially $36.0200 per share. Consequently, if the Convertible Notes are converted, then the number of shares to be issued by the Company would be effectively partially offset by the shares of common stock received by the Company under the Capped Calls as they are exercised. The formula above would be adjusted in the event of certain specified extraordinary events affecting the Company, including a merger; a tender offer; nationalization, insolvency or delisting of the Company’s common stock; changes in law; failure to deliver; insolvency filing; stock splits, combinations, dividends, repurchases or similar events; or an announcement of certain of the preceding actions.

Redeemable Perpetual Preferred

Redeemable Perpetual Preferred Stock	9 Months Ended
	Sep. 30, 2022
Temporary Equity Disclosure [Abstract]
Redeemable Perpetual Preferred Stock	Redeemable Perpetual Preferred Stock Series A Redeemable Perpetual Preferred Stock On August 10, 2021, the Company entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) pursuant to which, on August 11, 2021, the Company issued and sold to certain investors (the “Purchasers”) 350,000 shares of its newly designated Series A Redeemable Perpetual Preferred Stock and 7,098,765 shares of the Company’s common stock for an aggregate purchase price of $346.0 million (the “Initial Closing”). Further, pursuant to the Securities Purchase Agreement, on September 27, 2021, the Company issued and sold to the Purchasers 776,235 shares of common stock for an aggregate purchase price of $776.0 (the “Prepaid Forward Contract”). The Company used net proceeds from the Initial Closing to repay the entire $102.0 million amount outstanding under its existing Revolving Credit Facility and prepay $100.0 million under the Company’s Term Loan Facility. Additionally, the Securities Purchase Agreement entitles the Purchasers to designate one representative to be appointed to the Company’s board of directors (the “Board”) and to appoint three non-voting observers to the Board, in each case until such time as the Purchasers no longer beneficially own shares of the Series A Redeemable Perpetual Preferred Stock with at least $100 million aggregate Liquidation Preference (as defined below). The Series A Redeemable Perpetual Preferred Stock has no maturity date. On January 7, 2022, the Company issued and sold to the Purchasers 50,000 shares of Series A Redeemable Perpetual Preferred Stock and 1,125,000 shares of the Company’s common stock in an additional closing for an aggregate purchase price of $49.4 million (the “Additional Closing”). Additional Closings The Securities Purchase Agreement gives the Company the option to require the Purchasers to purchase, in one or more additional closings, up to 150,000 shares of Series A Redeemable Perpetual Preferred Stock until June 30, 2023 and up to 3,375,000 shares of common stock (or up to 6,100,000 shares of common stock in the event of certain price-related adjustments) (subject to certain equitable adjustments pursuant to any stock dividend, stock split, stock combination, reclassification or similar transaction) for an aggregate purchase price up to $148.0 million (the “Delayed Draw Commitment”). This commitment has been reduced by the Additional Closing. The Company evaluated the accounting for the instruments issued in the Securities Purchase Agreement and determined the Series A Redeemable Perpetual Preferred Stock and common stock issued in the Initial Closing, as well as the Prepaid Forward Contract, and Delayed Draw Commitment are freestanding instruments accounted for in equity. The Series A Redeemable Perpetual Preferred Stock is recorded in temporary equity on the condensed consolidated balance sheets as it has redemption features upon certain triggering events that are outside the Company’s control, such as a fundamental change. The proceeds of the Series A Redeemable Perpetual Preferred Stock, transactions costs and discount of $334.6 million have been allocated to each instrument based on its relative fair value. At the Initial Closing date, $229.8 million was allocated to the Series A Redeemable Perpetual Preferred Stock, $105.4 million to common stock, $12.4 million to the Delayed Draw Commitment, which was recorded as a debit to additional paid-in capital, and $11.7 million to the Prepaid Forward Contract. The Additional Closing carried issuance and original issuance discount costs of $1.3 million. The net proceeds were allocated amongst the Series A Redeemable Perpetual Preferred Stock and common stock based on the proceeds of $33.1 million and $15.9 million, respectively. Dividends On or prior to the fifth anniversary of the Initial Closing, the Company may pay dividends on the Series A Redeemable Perpetual Preferred Stock either in cash at the then-applicable Cash Regular Dividend Rate (as defined below), through accrual to the Liquidation Preference at the Accrued Regular Dividend Rate (as defined below) of 6.25% (the “Permitted Accrued Dividends”) or a combination thereof. Following the fifth anniversary of the Initial Closing, dividends are payable only in cash. To the extent the Company does not declare such dividends and pay in cash following the fifth anniversary of the Initial Closing, the dividends accrue to the Liquidation Preference (“Default Accrued Dividends”) at the then-applicable Cash Regular Dividend Rate plus 200 basis points. In the event there are Default Accrued Dividends outstanding for six consecutive quarters, the Company, at the option of the holders of the Series A Redeemable Perpetual Preferred Stock, will pay 100% of the amount of Default Accrued Dividends by delivering to such holder a number of shares of the Company’s common stock equal to the quotient of (i) the amount of Default Accrued Dividends divided by (ii) 95% of the 30-day VWAP of the Company’s common stock. As used herein, “Liquidation Preference” means, with respect to any shares of the Series A Redeemable Perpetual Preferred Stock, the initial liquidation preference of $1000 per share plus any accrued dividends of such share as the time of the determination. The “Cash Regular Dividend Rate” of the Series A Redeemable Perpetual Preferred Stock means (i) initially, 5.75% per annum on the Liquidation Preference and (ii) increased by (a) 50 basis points on each of the fifth, sixth and seventh anniversaries of the Initial Closing and (b) 100 basis points on each of the eighth, ninth and tenth anniversaries of the Initial Closing. The “Accrued Regular Dividend Rate” on the Series A Redeemable Perpetual Preferred Stock means 6.25% per annum on the Liquidation Preference. There are no Permitted Accrued Dividends accrued as of September 30, 2022 with dividends paid for the nine months ended September 30, 2022 $18.7 million (the “Q3 Dividend Payment”). Permitted Accrued Dividends resulted in 13 shares of the Series A Redeemable Perpetual Preferred Stock being issued as of September 30, 2022 which were settled with the Q3 Dividend Payment and no longer outstanding. Dividends declared and paid as of December 31, 2021 were $8.2 million. The shares of Series A Redeemable Perpetual Preferred Stock have similar characteristics of an “Increasing Rate Security” as described by SEC Staff Accounting Bulletin Topic 5Q, Increasing Rate Preferred Stock . As a result, the discount on Series A Redeemable Perpetual Preferred Stock is considered an unstated dividend cost that is amortized over the period preceding commencement of the perpetual dividend using the effective interest method, by charging imputed dividend cost against retained earnings, or additional paid in capital in the absence of retained earnings, and increasing the carrying amount of the Series A Redeemable Perpetual Preferred Stock by a corresponding amount. The discount of $120.2 million is therefore being amortized over five years using the effective yield method. The amortization in each period is the amount which, together with the stated dividend in the period, results in a constant rate of effective cost with regard to the carrying amount of the Series A Redeemable Perpetual Preferred Stock. The Company has presented the Series A Redeemable Perpetual Preferred Stock in temporary equity and is accreting the discount on the increasing rate dividends using the effective interest method. Such accretion totaled $17.2 million for the nine months ended September 30, 2022. The Company paid the cash dividend for the three months ended September 30, 2022 of $6.3 million in dividends at a rate of 5.75% as of September 30, 2022. Fees Until June 30, 2023, the Company will pay the Purchasers a cash commitment premium on the unpurchased portion of Delayed Draw Commitment as follows: a. 0% through the six-month anniversary of the Initial Closing; b. 1.5% from the six-month anniversary of the Initial Closing through the 12-month anniversary of the Initial Closing; and c. 3.0% from the 12-month anniversary of the Initial Closing through June 30, 2023. The Company may terminate some or all of the Delayed Draw Commitment, from time to time, at its sole discretion.

Revenue

Revenue	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Based on ASC 606 provisions, the Company disaggregates its revenue from contracts with customers by those sales recorded over-time and sales recorded at a point in time. The following table presents the Company’s revenue disaggregated by sales recorded over-time and sales recorded at a point in time (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Over-time revenue $ 458,405 $ 128,183 $ 991,561 $ 360,581 Point in time revenue 56,619 60,503 243,914 272,861 Total revenue $ 515,024 $ 188,686 $ 1,235,475 $ 633,442 As discussed in the consolidated financial statements included in the 2021 Annual Report, contracts related to the Company’s federal investment tax credit (“ITC”) were determined to have multiple performance obligations satisfied at a point in time instead of one performance obligation satisfied over time. The disaggregated revenue information above for the nine months ended September 30, 2021 has been restated to correct this error, which resulted in $223.2 million of revenue being reclassified from over-time revenue to point in time revenue for the nine months ended September 30, 2021. Revenue recognized for the ITC-related contracts and standalone system component sales is recorded at a point in time and recognized when obligations under the terms of the contract with the Company’s customer are satisfied. Generally, this occurs with the transfer of control of the asset, which is typically upon delivery to the customer in line with shipping terms. In certain situations, the Company recognizes revenue under a bill-and-hold arrangement with its customers. When this occurs, the customers purchase material prior to the start of construction of a solar project in order to meet the Five Percent Safe Harbor test to qualify for the ITC. Because the customers lack sufficient storage capacity to accept a large amount of material prior to the start of construction, they request that the Company keep the product in its custody. The material is bundled or palletized in the Company’s warehouses, identified separately as belonging to the respective customer and is ready for immediate transport to the customer project upon customer request. Additionally, title and risk of loss has passed to the customer and the Company does not have the ability to use the product or direct it to another customer. As of September 30, 2022, the Company had no contracts with customers for the sale of goods and services that contained bill-and-hold obligations such as storage, handling and other custodial duties for the three and nine months ended September 30, 2022. Any losses incurred on point-in-time projects are recognized as the goods are delivered . Contract Balances The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and deferred revenue (contract liabilities) on the condensed consolidated balance sheets. The majority of the Company’s contract amounts are billed as work progresses in accordance with agreed-upon contractual terms, which generally coincide with the shipment of one or more phases of the project. Billing sometimes occurs subsequent to revenue recognition, resulting in contract assets. The changes in contract assets (i.e., unbilled receivables) and the corresponding amounts recorded in revenue relate to fluctuations in the timing and volume of billings for the Company’s revenue recognized over-time. Contract assets consisting of unbilled receivables are recorded within accounts receivable on the condensed consolidated balance sheets on a contract-by-contract basis at the end of the reporting period and consisted of the following (in thousands): September 30, 2022 December 31, 2021 Unbilled receivables $ 136,953 $ 111,224 The Company also receives advances or deposits from its customers, before revenue is recognized, resulting in contract liabilities. The changes in contract liabilities (i.e., deferred revenue) relate to advanced orders and payments received by the Company. Contract liabilities consisting of deferred revenue recorded on a contract-by-contract basis at the end of each reporting period were as follows (in thousands): September 30, 2022 December 31, 2021 Deferred revenue $ 154,692 $ 99,575 During the nine months ended September 30, 2022, the Company converted $73.1 million in deferred revenue to revenue, which represented 73% of the prior year’s deferred revenue balance. Remaining Performance Obligations

Income (Loss) Per Share

Income (Loss) Per Share	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Income (Loss) Per Share	Income (Loss) Per Share The following table sets forth the computation of basic and diluted income (loss) per share (in thousands, except per share amounts): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Net income (loss) $ 40,822 $ (27,561) $ 13,542 $ (28,502) Preferred dividends and accretion 12,257 5,479 36,045 5,479 Net income (loss) to common shareholders $ 28,565 $ (33,040) $ (22,503) $ (33,981) Basic: Weighted average shares 150,322 130,955 149,604 128,315 Income (loss) per share $ 0.19 $ (0.25) $ (0.15) $ (0.26) Diluted: Effect of Restricted Stock and Performance Awards 1,060 — — — Weighted average shares 151,382 130,955 149,604 128,315 Income (loss) per share $ 0.19 $ (0.25) $ (0.15) $ (0.26) Potentially dilutive common shares issuance pursuant to equity-based awards of 108,111 were not included as their effect was anti-dilutive for the three months ended September 30, 2022. Potentially dilutive common shares issuable pursuant to equity-based awards of 2,504,046 and 1,203,520 were not included for the nine

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation The Company, in the normal course of business, is subject to claims and litigation. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company would accrue a liability for the estimated loss. On August 30, 2017, the Company filed its first amended complaint in the U.S. District Court for the District of New Mexico against Nextracker LLC, Daniel S. Shugar, Marco Garcia, Flextronics International U.S.A., Inc., Scott Graybeal and Colin Mitchell (collectively, the “Defendants”) asserting (among other claims) trade secret misappropriation, tortious interference with contract, fraud, and breach of contract (the “Nextracker Litigation”). On July 15, 2022, the Company settled its claims against Defendants for $42.8 million and received payment on August 4, 2022. On May 14, 2021, a putative class action was filed in the U.S. District Court for the Southern District of New York (the “Southern District of New York” or the “Court”) against the Company and certain officers and directors alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5, promulgated thereunder, and Sections 11, 12(a)(2) and 15 of the Securities Exchange Act of 1933 (“Plymouth Action”). The Plymouth Action alleges misstatements and/or omissions in the Company’s registration statements and prospectuses related to the Company’s October 2020 initial public offering (“IPO”), the Company’s December 2020 offering (the “2020 Follow-On Offering”), and the Company’s March 2021 offering (the “2021 Follow-On Offering”) during the putative class period of October 14, 2020 through May 11, 2021. On June 30, 2021, a second putative class action was filed in the Southern District of New York against the Company and certain officers and directors alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5, promulgated thereunder, and Sections 11 and 15 of the Securities Exchange Act of 1933 (“Keippel Action”). The Keippel Action similarly alleged misstatements and/or omissions in certain of the Company’s registration statements and prospectuses related to the Company’s IPO, the Company’s 2020 Follow-On Offering, and the Company’s 2021 Follow-On Offering during the putative class period of October 14, 2020 through May 11, 2021. On July 6, 2021, the Court entered an order that the Keippel Action was in all material respects substantially similar to the Plymouth Action that both actions arise out of the same or similar operative facts, and that the parties are substantially the same parties. The Court accordingly consolidated the Keippel Action with the Plymouth Action for all pretrial purposes and, ordered all filings to be made in the Plymouth Action. On July 16, 2021, a verified derivative complaint was filed in the Southern District of New York against certain officers and directors of the Company (“First SDNY Derivative Action”). The complaint alleges: (1) violations of Section 14(a) of the Securities Exchange Act of 1934 for misleading proxy statements, (2) breach of fiduciary duty, (3) unjust enrichment, (4) abuse of control, (5) gross mismanagement, (6) corporate waste, (7) aiding and abetting breach of fiduciary duty, and (8) contribution under sections 10(b) and 21D of the Securities Exchange Act of 1934. On July 30, 2021, a second and related verified derivative complaint was filed in the Southern District of New York against certain officers and directors of the Company (“Second SDNY Derivative Action”). The complaint alleges: (1) violations of Section 14(a) of the Securities Exchange Act of 1934 for causing the issuance of a false/misleading proxy statement, (2) breach of fiduciary duty, and (3) aiding and abetting breaches of fiduciary duty. On August 24, 2021, the Second SDNY Derivative Action was consolidated with the First SDNY Derivative Action, the Court appointed co-lead counsel, and the case was temporarily stayed pending the entry of an order on all motions to dismiss directed at the pleadings filed in the Plymouth Action. The stay shall remain in effect until the later of (a) the entry of an order on any motions to dismiss the Plymouth Action or, (b) to the extent the complaint in the Plymouth Action is amended, the entry of an order on any motions to dismiss any such amended complaints in the Plymouth Action. On September 21, 2021, the Court in the Plymouth Action appointed a group comprised of institutional investors Plymouth County Retirement Association and Carpenters Pension Trust Fund for Northern California as lead plaintiff. On December 7, 2021, an amended class action complaint was filed by lead plaintiff in the Plymouth Action against the Company and certain officers and directors alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5, promulgated thereunder, and Sections 11, 12(a)(2), and 15 of the Securities Exchange Act of 1933, on behalf of a putative class of persons and entities that purchased or otherwise acquired the Company’s securities during the period from October 14, 2020 through May 11, 2021 (the “Consolidated Amended Complaint”). The Consolidated Amended Complaint alleges misstatements and/or omissions in: (1) certain of the Company’s registration statements and prospectuses related to the Company’s IPO, the Company’s 2020 Follow-On Offering, and the Company’s 2021 Follow-On Offering; (2) in the Company’s Annual Report on Form 10-K and associated press release announcing results for the fourth quarter and full fiscal year 2020; and (3) in the Company’s November 5, 2020 and March 9, 2021 earnings calls. On August 17, 2022, the Court in the Plymouth Action set a briefing schedule for any motion to dismiss with the opening motion and supporting memorandum to be filed on or before October 17, 2022, any opposition to be filed on or before December 16, 2022, and any reply in support of the motion to be filed on or before January 16, 2023. The Company and other defendants in the Plymouth Action filed a joint motion to dismiss the Consolidated Amended Complaint on October 17, 2022. On August 3, 2022, a verified derivative complaint was filed in the Court of Chancery of the State of Delaware (the “Court of Chancery”) against certain officers and directors of the Company, asserting claims for: (1) breach of fiduciary duty and (2) unjust enrichment (“First Delaware Derivative Action”). On August 11, 2022, a second verified derivative complaint was filed against certain officers and directors of the Company Court of Chancery, asserting claims for: (1) breach of fiduciary duty; (2) aiding and abetting breaches of fiduciary duty; (3) waste of corporate assets; (4) unjust enrichment; (5) insider selling; and (6) aiding and abetting insider selling (“Second Delaware Derivative Action”). On September 2, 2022, the Second Delaware Derivative Action was consolidated with the First Delaware Derivative Action, the Court of Chancery appointed co-lead counsel, and the case was temporarily stayed pending the entry of an order on all motions to dismiss directed at the pleadings filed in the Plymouth Action. The stay shall remain in effect until the later of (a) the entry of an order on the pending motion to dismiss the Consolidated Amended Complaint in the Plymouth Action, (b) to the extent the Consolidated Amended Complaint in the Plymouth Action is further amended, the entry of an order on any motions to dismiss any such amended complaints in the Plymouth Action, or (c) the public announcement of a settlement of the Plymouth Action. At this time the Company believes that the likelihood of any material loss related to these matters is remote given the preliminary stage of the claims and strength of the defenses. The Company has not recorded any material loss contingency in the condensed consolidated balance sheets as of September 30, 2022 or December 31, 2021. Contingent Consideration Tax Receivable Agreement Concurrent with the Former Parent’s acquisition of Array Technologies Patent Holdings Co., LLC on July 8, 2016, Array Tech, Inc. entered into a Tax Receivable Agreement (the “TRA”) with the former majority shareholder of Array. The TRA is valued based on the future expected payments under the agreement. The TRA provides for the payment by Array Tech, Inc. to the former owners for certain federal, state, local and non-U.S. tax benefits deemed realized in post-closing taxable periods by Array, from the use of certain deductions generated by the increase in the tax value of the developed technology. The TRA is accounted for as contingent consideration and subsequent changes in fair value of the contingent liability are recognized in contingent consideration in the condensed consolidated statements of operations. As of September 30, 2022 and December 31, 2021, the fair value of the TRA was $7.1 million and $14.6 million, respectively. Estimating the amount of payments that may be made under the TRA is by nature imprecise. The significant fair value inputs used to estimate the future expected TRA payments to the former owners include the timing of tax payments, a discount rate, book income projections, timing of expected adjustments to calculate taxable income and the projected rate of use for attributes defined in the TRA. Payments made under the TRA consider tax positions taken by the Company and are due within 125 days following the filing of the Company’s U.S. federal and state income tax returns under procedures described in the agreement. The current portion of the TRA liability is based on tax returns. The TRA will continue until all tax benefit payments have been made or the Company elects early termination under the terms described in the TRA. The following table summarizes the liability related to the estimated TRA (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Beginning balance $ 7,686 $ 12,016 $ 14,577 $ 19,691 Payments — — (1,483) (7,810) Fair value adjustment (573) 936 (5,981) 1,071 Ending balance $ 7,113 $ 12,952 $ 7,113 $ 12,952 The TRA liability requires significant judgment and is classified as Level 3 in the fair value hierarchy. Surety Bonds

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying values and the estimated fair values of debt financial instruments were as follows (in thousands): September 30, 2022 December 31, 2021 Carrying Value Fair Value Carrying Value Fair Value Convertible Notes $ 413,279 $ 381,625 $ 411,863 $ 410,771 The carrying values of the Revolving Credit Facility recorded in long-term debt on the condensed consolidated balance sheets approximate fair value due to the variable interest rate. The fair value of the Convertible Notes is estimated using Level 2 inputs, as they are not registered securities nor listed on any securities exchange but may be traded by qualified institutional buyers.

Equity-Based Compensation

Equity-Based Compensation	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Equity-Based Compensation	Equity-Based Compensation 2020 Plan On October 14, 2020, the Company’s 2020 Equity Incentive Plan (the “2020 Plan”) became effective. The 2020 Plan authorized 6,683,919 new shares, subject to adjustments pursuant to the 2020 Plan. During the nine months ended September 30, 2022, the Company granted an aggregate of 1,433,829 restricted stock units (“RSUs”) to employees and board of director members and 466,916 performance stock units (“PSUs”) to certain executives. The fair value of the RSUs is determined using the market value of common stock on the grant date. The PSUs cliff vest after three years and upon meeting certain revenue and adjusted EPS targets. The PSUs also contain a modifier based on the total stock return (TSR) compared to a certain index which modifies the number of PSUs that vest. The PSUs were valued using a Monte-Carlo simulation method with a volatility assumption of 66% - 79%, risk free interest rate of 0.28% - 2.79% based on the United States Treasury Constant Maturity rates and no dividends paid assumption. Activity under the 2020 Plan was as follows: RSUs Number of Shares Weighted Average Grant Date Fair Value Unvested, December 31, 2021 930,409 $ 21.66 Granted 1,433,829 $ 10.16 Vested (278,792) $ 18.68 Forfeited (127,325) $ 18.50 Unvested, September 30, 2022 1,958,121 $ 13.97 PSUs Number of Shares Weighted Average Grant Date Fair Value Unvested, December 31, 2021 147,687 $ 27.75 Granted 466,916 $ 10.88 Vested — $ — Forfeited (68,678) $ 30.74 Unvested, September 30, 2022 545,925 $ 12.95 Class B Units and Class C Units of Former Parent The Company accounted for equity grants to employees of Class B Units and Class C Units (collectively, the “Units”) of Former Parent as equity-based compensation under ASC 718, Compensation-Stock Compensation . The Units contain vesting provisions as defined in the agreement. Vested Units do not forfeit upon termination and represent a residual interest in Former Parent. Equity-based compensation cost is measured at the grant date fair value and is recognized on a straight-line basis over the requisite service period, including those Units with graded vesting with a corresponding credit to additional paid-in capital as a capital contribution from Former Parent. However, the amount of equity-based compensation at any date is equal to the portion of the grant date value of the award that is vested. The Units issued to employees are measured at fair value on the grant date using an option pricing model. The Company utilizes the estimated weighted average of the Company’s expected fund life dependent on various exit scenarios to estimate the expected term of the awards. Expected volatility is based on the average of historical and implied volatility of a set of comparable companies, adjusted for size and leverage. The risk-free rates are based on the yields of U.S. Treasury instruments with comparable terms. Actual results may vary depending on the assumptions applied within the model. On November 19, 2019 and May 19, 2020, Former Parent issued 22,326,653 and 4,344,941, respectively, Class B Units to certain employees of the Company. On March 28, 2020, Former Parent issued 1,000 Class C Units to a member of the board of directors of Array Technologies, Inc. On March 23, 2021, in connection with the closing of the 2021 Follow-On Offering, all of the outstanding Class B Units of Former Parent were immediately vested per the terms of the equity awards, resulting in the Company accelerating the recognition of equity-based compensation of $8.9 million for the nine months ended September 30, 2021. For the three months ended September 30, 2022 and 2021, the Company recognized $4.2 million and $2.2 million in equity-based compensation, respectively. For the nine months ended September 30, 2022 and 2021, the Company recognized $11.7 million and $14.3 million in equity-based compensation, respectively. As of September 30, 2022, the Company had $23.0 million of unrecognized compensation costs related to RSUs and PSUs which is expected to be recognized over a period of 2 years. There were 76,936 and 196,003 forfeitures during the three and nine months ended September 30, 2022 and 18,772 and 79,277 forfeitures during the three and nine months ended September 30, 2021, respectively.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Accounts Payable-Related Party The Company had $0.5 million and $0.6 million as of September 30, 2022 and December 31, 2021, respectively, of accounts payable-related party with the former shareholders of Array. The payables relate to a federal tax refund related to the pre-acquisition periods and restricted cash related to Former Parent’s acquisition of the Company which were due to the sellers of Array upon release of the restriction offset by a receivable related to a sales/use tax audit from the pre-acquisition period for which the seller provided the Company with indemnification. Tax Receivable Agreement See Note 16 – Commitments and Contingencies – Tax Receivable Agreement.

Segment Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting ASC 280 Segment Reporting establishes standards for reporting information about operating segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Historically, the Company managed its business on the basis of one operating and reportable segment. During the nine months ended September 30, 2022, the Company changed its reportable segments as a result of the STI Acquisition; the Company now operates as two segments; Array Legacy Operations and STI Operations. The following table provides a reconciliation of certain financial information for the Company’s reportable segments to information presented in its condensed consolidated financial statements for the three and nine months ended September 30, 2022 and 2021 and as of September 30, 2022 and December 31, 2021 (in thousands): Three Months Ended September 30, 2022 Three Months Ended September 30, 2021 Array Legacy Operations STI Operations Total Array Legacy Operations Revenue $ 400,463 $ 114,561 $ 515,024 $ 188,686 Gross Profit $ 63,921 $ 16,302 $ 80,223 $ 5,897 Nine Months Ended September 30, 2022 Nine Months Ended September 30, 2021 Array Legacy Operations STI Operations Total Array Legacy Operations Revenue $ 998,292 $ 237,183 $ 1,235,475 $ 633,442 Gross Profit $ 119,029 $ 27,727 $ 146,756 $ 72,570

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Accounting and Presentation	Basis of Accounting and PresentationThe accompanying unaudited condensed consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). The unaudited interim financial statements have been prepared on the same basis as the audited annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of results for the interim periods reported. The results for the three and nine months ended September 30, 2022 are not necessarily indicative of results to be expected for the year ending December 31, 2022 or any other interim periods, or any future year or period. The balance sheet as of December 31, 2021 included herein was derived from the audited financial statements as of that date. Certain disclosures have been condensed or omitted from the interim financial statements. These financial statements should be read in conjunction with the Company’s audited financial statements included in the Company’s Annual Report on Form 10-K filed with the SEC on April 6, 2022, as amended by the Form 10-K/A filed with the SEC on April 6, 2022 (the “2021 Annual Report”).
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated upon consolidation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates include evaluation for any impairment of goodwill, impairment of long-lived assets, fair value of contingent consideration, Series A Redeemable Perpetual Preferred Stock and the related future tranche, allowance for credit losses, reserve for excess or obsolete inventories, valuation of deferred tax assets and warranty reserve. Actual results may differ from previously estimated amounts, and such differences may be material to the condensed consolidated financial statements; however, management believes that these estimates and assumptions provide a reasonable basis for the fair presentation of the consolidated financial statements. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the period they occur.
Impact of COVID-19 Pandemic and Impact of the Ongoing Conflict in Ukraine	Impact of COVID-19 Pandemic The Company continues to closely monitor the ongoing impact of the COVID-19 pandemic in all the locations where it operates. The Company’s priority remains the welfare of its employees. The Company expects persistent waves of COVID-19, including variants of the virus, to remain a headwind into the near future. The duration and extent to which it will continue to adversely impact the Company’s business and results of operations remain uncertain and could be material. The Company believes it has sufficient liquidity and financing options available and expects to have sufficient liquidity to operate for the next 12 months. The Company expects to use cash generated from operations and if needed, can access funds from the Revolving Credit Facility (as defined below). The Company also has $100 million in delayed draw ability under the Series A Redeemable Perpetual Preferred Stock (as defined below) future draw commitment; however, such a draw would increase the Company’s dividend obligations and outstanding common stock and failure to draw the delayed commitments will result in interest expense payable by the Company. See Note 13 – Redeemable Perpetual Preferred Stock . The Revolving Credit Facility has $166.6 million of availability. Impact of the Ongoing Conflict in Ukraine The ongoing conflict in Ukraine has reduced the availability of material that can be sourced in Europe and, as a result, increased logistics costs for the procurement of certain inputs and materials used in our products. We do not know ultimate severity or duration of the conflict in Ukraine, but we continue to monitor the situation and evaluate our procurement strategy and supply chain as to reduce any negative impact on our business, financial condition and results of operations.
Inflation	Inflation The Company could see an impact from elevated inflation and other operating costs. Interest rates have increased quickly and substantially as central banks in developed countries raise interest rates in an effort to subdue inflation, while government deficits and debt remain at high levels in many global markets. The eventual implications of higher government deficits and debt, tighter monetary policy, and potentially higher long-term interest rates may drive a higher cost of capital during our forecast period.
Business Combinations	Business Combinations The Company accounts for its business acquisitions under the acquisition method of accounting in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 805 Business Combinations (“ASC 805”). The excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill. Determining the fair value of assets acquired and liabilities assumed requires management’s judgment and often involves the use of significant estimates and assumptions, including assumptions with respect to future cash inflows and outflows, discount rates, asset lives, and market multiples, amongst other items.
Foreign Currency Translation	Foreign Currency Translation For non-U.S. subsidiaries that operate in a local currency environment, assets and liabilities are translated into the U.S. dollar at period end exchange rates. Income, expense and cash flow items are translated at average exchange rates prevailing during the period. Translation adjustments for these subsidiaries are accumulated as a separate component of accumulated other comprehensive income in equity. For non-U.S. subsidiaries that use a U.S. dollar functional currency, local currency inventories and property, plant and equipment are translated into U.S. dollars at rates prevailing when acquired, and all other assets and liabilities are translated at period end exchange rates. Inventories charged to cost of revenue and depreciation are remeasured at historical rates, and all other income and expense items are translated at average exchange rates prevailing during the period. Gains and losses which result from remeasurement are included in earnings.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Adopted In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ ASU 2021-08”). ASU 2021-08 requires the company acquiring contract assets and contract liabilities obtained in a business combination to recognize and measure them in accordance with ASC Topic 606, Revenue from Contracts with Customers (“ ASC 606”). At the acquisition date, the company acquiring the business should record related revenue, as if it had originated the contract. Before the recent update, such amounts were recognized by the acquiring company at fair value. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted, including in interim periods, for any financial statements that have not yet been issued. The Company early adopted ASU 2021-08 as of January 1, 2022. See Note 3 – Acquisition of STI for further information and disclosures related to the STI Acquisition. The standard was applied to the acquisition accounting for STI. A review of the deferred revenue of the acquiree of $20.3 million was reviewed for consistency in application with the Company’s policies and U.S. GAAP and the contract liability balance was carried over at its carrying value.

Acquisition of STI (Tables)

Acquisition of STI (Tables)	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of business acquisitions purchase price consideration	The purchase price consideration to acquire STI consisted of the following (in thousands): Cash consideration for STI $ 409,647 Cash consideration for transaction expenses of STI 896 Total cash consideration 410,543 Non-cash equity consideration 200,224 Total consideration transferred 610,767 Total purchase price consideration $ 610,767
Schedule of business acquisitions, by acquisition	The following table summarizes the preliminary estimates of fair values of the assets acquired and liabilities assumed as of the Acquisition Date (in thousands): Preliminary Fair Value of Net Assets Acquired and Liabilities Assumed: Acquisition Date Measurement Adjustment September 30, 2022 Cash and cash equivalents $ 36,725 $ — $ 36,725 Accounts receivable 110,789 — 110,789 Inventories 47,517 — 47,517 Prepaid expenses and other 23,399 — 23,399 Property, plant and equipment 4,434 — 4,434 Other intangible assets 318,365 — 318,365 Other assets 325 — 325 Total assets acquired $ 541,554 $ — $ 541,554 Accounts payable 65,761 — 65,761 Deferred revenue 20,345 — 20,345 Short-term debt 44,338 — 44,338 Other liabilities 10,115 — 10,115 Income tax payable 7,576 — 7,576 Deferred tax liability 93,823 7,611 101,434 Other long-term liabilities 4,524 — 4,524 Long-term debt 12,053 — 12,053 Total liabilities assumed $ 258,535 $ 7,611 $ 266,146 Preliminary fair value of net assets acquired 283,019 275,408 Preliminary allocation to goodwill $ 327,748 $ 335,359
Schedule of purchase price allocation	The preliminary purchase price allocation includes $318.4 million of acquired identifiable intangible assets. Estimated Fair Value Estimated Weighted Average Useful Life in Years (in thousands, except useful lives) Backlog $ 51,165 1 Customer relationships 238,770 10 Trade name 28,430 20 Total $ 318,365
Schedule of business acquisition, pro forma information	The following unaudited pro forma financial information presents the combined results of operations of the Company and STI as if the acquisition had occurred on January 1, 2021, after giving effect to certain unaudited pro forma adjustments. The unaudited pro forma adjustments reflected herein include only those adjustments that are directly attributable to the STI Acquisition including amortization of intangibles, debt financing expenses and tax benefits. The unaudited pro forma financial information does not reflect any adjustments for anticipated expense savings resulting from the STI Acquisition and is not necessarily indicative of the operating results that would have actually occurred had the STI Acquisition been consummated on January 1, 2021. Three Months Ended Nine Months Ended (in millions) 2022 2021 2022 2021 Revenue $ 515.0 $ 480.1 $ 1,243.0 $ 764.8 Net income (loss) $ 52.1 $ (22.7) $ 48.7 $ (44.6)

Accounts Receivable (Tables)

Accounts Receivable (Tables)	9 Months Ended
	Sep. 30, 2022
Receivables [Abstract]
Schedule of account receivable	Accounts receivable consists of the following (in thousands): September 30, 2022 December 31, 2021 Accounts receivable $ 485,869 $ 236,149 Less: allowance for doubtful accounts (695) (140) Accounts receivable, net $ 485,174 $ 236,009

Inventory (Tables)

Inventory (Tables)	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Schedule of current inventory	Inventories consist of the following (in thousands): September 30, 2022 December 31, 2021 Raw materials $ 166,260 $ 85,470 Finished goods 108,597 127,598 Reserve for excess or obsolete inventory (5,082) (7,415) Total $ 269,775 $ 205,653

Property, Plant, and Equipment

Property, Plant, and Equipment (Tables)	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Summary of property, plant and equipment	Property, plant and equipment consisted of the following (in thousands, except useful lives): Estimated Useful Lives (Years) September 30, 2022 December 31, 2021 Land N/A $ 1,563 $ 1,340 Buildings and land improvements 15-39 7,318 2,451 Manufacturing equipment 7 17,893 13,924 Furniture, fixtures and equipment 5-7 3,341 476 Vehicles 5 527 161 Hardware and software 3-5 2,487 1,683 Assets in progress 3,684 1,880 Total 36,813 21,915 Less: accumulated depreciation (16,789) (11,223) Property, plant and equipment, net $ 20,024 $ 10,692

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of goodwill	Changes in the carrying amount of goodwill by operating segment during the nine months ended September 30, 2022 are shown below (in thousands): Array Legacy Operations Segment STI Operations Segment Total Beginning Balance $ 69,727 $ — $ 69,727 Acquisition of STI — 335,359 $ 335,359 Foreign currency impact — (45,457) $ (45,457) Ending Balance $ 69,727 $ 289,902 $ 359,629
Schedule of finite-lived intangible assets	Other intangible assets consisted of the following (in thousands, except useful lives): Estimated Useful Lives (Years) September 30, 2022 December 31, 2021 Amortizable: Costs: Developed technology 14 $ 203,800 $ 203,800 Customer relationships 10 295,405 89,500 Backlog 1 44,132 — Trade name 20 24,518 — Total amortizable intangibles 567,855 293,300 Accumulated amortization: Developed technology 90,709 79,790 Customer relationships 70,606 49,057 Backlog 31,794 — Trade name 962 — Total accumulated amortization 194,071 128,847 Total amortizable intangibles, net 373,784 164,453 Non-amortizable costs: Trade name 10,300 10,300 Total other intangible assets, net $ 384,084 $ 174,753
Schedule of indefinite-lived intangible assets	Other intangible assets consisted of the following (in thousands, except useful lives): Estimated Useful Lives (Years) September 30, 2022 December 31, 2021 Amortizable: Costs: Developed technology 14 $ 203,800 $ 203,800 Customer relationships 10 295,405 89,500 Backlog 1 44,132 — Trade name 20 24,518 — Total amortizable intangibles 567,855 293,300 Accumulated amortization: Developed technology 90,709 79,790 Customer relationships 70,606 49,057 Backlog 31,794 — Trade name 962 — Total accumulated amortization 194,071 128,847 Total amortizable intangibles, net 373,784 164,453 Non-amortizable costs: Trade name 10,300 10,300 Total other intangible assets, net $ 384,084 $ 174,753
Schedule of future annual amortization expense of amortizable intangible assets	Estimated future annual amortization expense for the above amortizable intangible assets for the remaining periods through September 30, as follows (in thousands): Amount 2022 $ 22,365 2023 46,633 2024 45,328 2025 45,328 2026 41,021 Thereafter 173,109 $ 373,784

Senior Secured Credit Facility

Senior Secured Credit Facility (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of long-term debt instruments	Long-term senior secured credit facility consisted of the following (in thousands): September 30, 2022 December 31, 2021 Term loan facility $ 323,550 $ 326,775 Revolving credit facility — — 323,550 326,775 Less discount and issuance costs (20,169) (23,291) Long-term portion, net of debt discount and issuance costs 303,381 303,484 Less current portion of credit facility (4,300) (4,300) Long-term senior secured facility debt, net of current portion, debt discount and issuance costs $ 299,081 $ 299,184

Convertible Debt (Tables)

Convertible Debt (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Summary of convertible debt	Convertible debt consisted of the following (in thousands): September 30, 2022 December 31, 2021 1.00% Senior unsecured convertible notes $ 425,000 $ 425,000 Less: unamortized discount and issuance costs (11,721) (13,137) 1.00% Senior unsecured convertible notes, net (1) $ 413,279 $ 411,863 (1) Effective interest rate for the Convertible Notes as of September 30, 2022 and December 31, 2021 was 1.5%.

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of revenue	The following table presents the Company’s revenue disaggregated by sales recorded over-time and sales recorded at a point in time (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Over-time revenue $ 458,405 $ 128,183 $ 991,561 $ 360,581 Point in time revenue 56,619 60,503 243,914 272,861 Total revenue $ 515,024 $ 188,686 $ 1,235,475 $ 633,442 Contract assets consisting of unbilled receivables are recorded within accounts receivable on the condensed consolidated balance sheets on a contract-by-contract basis at the end of the reporting period and consisted of the following (in thousands): September 30, 2022 December 31, 2021 Unbilled receivables $ 136,953 $ 111,224 September 30, 2022 December 31, 2021 Deferred revenue $ 154,692 $ 99,575

Income (Loss) Per Share (Tables

Income (Loss) Per Share (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of earnings per share, basic and diluted	The following table sets forth the computation of basic and diluted income (loss) per share (in thousands, except per share amounts): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Net income (loss) $ 40,822 $ (27,561) $ 13,542 $ (28,502) Preferred dividends and accretion 12,257 5,479 36,045 5,479 Net income (loss) to common shareholders $ 28,565 $ (33,040) $ (22,503) $ (33,981) Basic: Weighted average shares 150,322 130,955 149,604 128,315 Income (loss) per share $ 0.19 $ (0.25) $ (0.15) $ (0.26) Diluted: Effect of Restricted Stock and Performance Awards 1,060 — — — Weighted average shares 151,382 130,955 149,604 128,315 Income (loss) per share $ 0.19 $ (0.25) $ (0.15) $ (0.26)

Commitment and Contingencies (T

Commitment and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Summary of liability related to estimated contingent consideration	The following table summarizes the liability related to the estimated TRA (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Beginning balance $ 7,686 $ 12,016 $ 14,577 $ 19,691 Payments — — (1,483) (7,810) Fair value adjustment (573) 936 (5,981) 1,071 Ending balance $ 7,113 $ 12,952 $ 7,113 $ 12,952

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of carrying values and estimated fair values of debt instruments	The carrying values and the estimated fair values of debt financial instruments were as follows (in thousands): September 30, 2022 December 31, 2021 Carrying Value Fair Value Carrying Value Fair Value Convertible Notes $ 413,279 $ 381,625 $ 411,863 $ 410,771

Equity-Based Compensation (Tabl

Equity-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Disclosure of share-based compensation arrangements by share-based payment award	Activity under the 2020 Plan was as follows: RSUs Number of Shares Weighted Average Grant Date Fair Value Unvested, December 31, 2021 930,409 $ 21.66 Granted 1,433,829 $ 10.16 Vested (278,792) $ 18.68 Forfeited (127,325) $ 18.50 Unvested, September 30, 2022 1,958,121 $ 13.97 PSUs Number of Shares Weighted Average Grant Date Fair Value Unvested, December 31, 2021 147,687 $ 27.75 Granted 466,916 $ 10.88 Vested — $ — Forfeited (68,678) $ 30.74 Unvested, September 30, 2022 545,925 $ 12.95

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Schedule of segment reporting information, by segment	The following table provides a reconciliation of certain financial information for the Company’s reportable segments to information presented in its condensed consolidated financial statements for the three and nine months ended September 30, 2022 and 2021 and as of September 30, 2022 and December 31, 2021 (in thousands): Three Months Ended September 30, 2022 Three Months Ended September 30, 2021 Array Legacy Operations STI Operations Total Array Legacy Operations Revenue $ 400,463 $ 114,561 $ 515,024 $ 188,686 Gross Profit $ 63,921 $ 16,302 $ 80,223 $ 5,897 Nine Months Ended September 30, 2022 Nine Months Ended September 30, 2021 Array Legacy Operations STI Operations Total Array Legacy Operations Revenue $ 998,292 $ 237,183 $ 1,235,475 $ 633,442 Gross Profit $ 119,029 $ 27,727 $ 146,756 $ 72,570

Organization and Business - Nar

Organization and Business - Narrative (Details) - segment	9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021	Jan. 11, 2022
Business Acquisition, Contingent Consideration [Line Items]
Number of operating segments	2	2	1
STI
Business Acquisition, Contingent Consideration [Line Items]
Percentage of share capital acquired				100%

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	Sep. 30, 2022	Jan. 11, 2022	Dec. 31, 2021	Feb. 26, 2021	Oct. 14, 2020
STI
Debt Instrument [Line Items]
Deferred revenue	$ 20,345,000	$ 20,345,000
Revolving credit facility
Debt Instrument [Line Items]
Maximum borrowing capacity				$ 150,000,000	$ 150,000,000
Available borrowing capacity	166,600,000		$ 186,400,000
Series A Redeemable Perpetual Preferred Stock
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 100,000,000

Acquisition of STI - Narrative

Acquisition of STI - Narrative (Details) - USD ($)		9 Months Ended
	Jan. 11, 2022	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Temporary equity, par value (in dollars per share)		$ 0.001	$ 0.001	$ 0.001
Percentage, estimated royalty rate	1.25%
Percentage, weighted average cost of capital, discount rate	15.20%
SPAIN | Customer relationships
Business Acquisition [Line Items]
Percentage of weighted average cost of capital	15%
SPAIN | Customer relationship for foreign sourced projects
Business Acquisition [Line Items]
Percentage of weighted average cost of capital	14%
SPAIN | Backlog
Business Acquisition [Line Items]
Percentage of weighted average cost of capital	8.50%
SPAIN | Order backlog for foreign sourced projects
Business Acquisition [Line Items]
Percentage of weighted average cost of capital	7.50%
BRAZIL | Customer relationships
Business Acquisition [Line Items]
Percentage of weighted average cost of capital	16.50%
BRAZIL | Backlog
Business Acquisition [Line Items]
Percentage of weighted average cost of capital	9.50%
STI
Business Acquisition [Line Items]
Cash consideration for transaction expenses of STI	$ (896,000)		$ 5,600,000
Total cash consideration	$ 410,543,000
Business acquisition, equity interest issued or issuable, number of shares (in shares)	13,894,800
Total consideration transferred	$ 610,767,000
Percentage of share capital acquired	100%
Goodwill, expected tax deductible amount	$ 0
Acquired identifiable intangible assets	$ 318,365,000	$ 318,365,000	$ 318,365,000
Pro forma information, revenue of acquiree since acquisition date, actual		237,200,000
Pro forma information, net loss of acquiree since acquisition date, actual		$ (14,100,000)
Series A Redeemable Perpetual Preferred Stock
Business Acquisition [Line Items]
Temporary equity, par value (in dollars per share)	$ 0.001

Acquisition of STI - Schedule o

Acquisition of STI - Schedule of Business Acquisitions Purchase Price Consideration (Details) - USD ($) $ in Thousands		9 Months Ended
	Jan. 11, 2022	Sep. 30, 2022	Sep. 30, 2021
Business Acquisition [Line Items]
Non-cash equity consideration		$ 200,224	$ 0
STI
Business Acquisition [Line Items]
Cash consideration for STI	$ 409,647
Cash consideration for transaction expenses of STI	896	$ (5,600)
Total cash consideration	410,543
Non-cash equity consideration	200,224
Total consideration transferred	$ 610,767

Acquisition of STI - Schedule_2

Acquisition of STI - Schedule of Business Acquisitions, by Acquisition (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Jan. 11, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Preliminary allocation to goodwill	$ 359,629		$ 69,727
STI
Business Acquisition [Line Items]
Cash and cash equivalents	36,725	$ 36,725
Accounts receivable	110,789	110,789
Inventories	47,517	47,517
Prepaid expenses and other	23,399	23,399
Property, plant and equipment	4,434	4,434
Other intangible assets	318,365	318,365
Other assets	325	325
Total assets acquired	541,554	541,554
Accounts payable	65,761	65,761
Deferred revenue	20,345	20,345
Short-term debt	44,338	44,338
Other liabilities	10,115	10,115
Income tax payable	7,576	7,576
Deferred tax liability	101,434	93,823
Deferred tax liability, measurement adjustment	7,611
Other long-term liabilities	4,524	4,524
Long-term debt	12,053	12,053
Total liabilities assumed	266,146	258,535
Total liabilities assumed, measurement adjustment	7,611
Preliminary fair value of net assets acquired	275,408	283,019
Preliminary allocation to goodwill	$ 335,359	$ 327,748

Acquisition of STI - Schedule_3

Acquisition of STI - Schedule of Purchase Price Allocation (Details) - STI - USD ($) $ in Thousands	Jan. 11, 2022	Sep. 30, 2022
Business Acquisition [Line Items]
Acquired identifiable intangible assets	$ 318,365	$ 318,365
Trade name
Business Acquisition [Line Items]
Indefinite-lived intangible, estimated fair value	$ 28,430
Intangible assets, estimated weighted average useful life (in years)	20 years
Backlog
Business Acquisition [Line Items]
Finite-lived intangibles, estimated fair value	$ 51,165
Intangible assets, estimated weighted average useful life (in years)	1 year
Customer relationships
Business Acquisition [Line Items]
Finite-lived intangibles, estimated fair value	$ 238,770
Intangible assets, estimated weighted average useful life (in years)	10 years

Acquisition of STI - Business A

Acquisition of STI - Business Acquisition, Pro Forma Information (Details) - STI - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Business Acquisition [Line Items]
Revenue	$ 515	$ 480.1	$ 1,243	$ 764.8
Net income (loss)	$ 52.1	$ (22.7)	$ 48.7	$ (44.6)

Accounts Receivable (Details)

Accounts Receivable (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Receivables [Abstract]
Accounts receivable	$ 485,869	$ 236,149
Less: allowance for doubtful accounts	(695)	(140)
Accounts receivable, net	$ 485,174	$ 236,009

Inventory (Details)

Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 166,260	$ 85,470
Finished goods	108,597	127,598
Reserve for excess or obsolete inventory	(5,082)	(7,415)
Inventories, net	$ 269,775	$ 205,653

Property, Plant, and Equipmen_2

Property, Plant, and Equipment - Summary of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 36,813	$ 21,915
Less: accumulated depreciation	(16,789)	(11,223)
Property, plant and equipment, net	20,024	10,692
Land
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	1,563	1,340
Buildings and land improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 7,318	2,451
Buildings and land improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives (Years)	15 years
Buildings and land improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives (Years)	39 years
Manufacturing equipment
Property, Plant and Equipment [Line Items]
Estimated Useful Lives (Years)	7 years
Property, plant, and equipment, gross	$ 17,893	13,924
Furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 3,341	476
Furniture, fixtures and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives (Years)	5 years
Furniture, fixtures and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives (Years)	7 years
Vehicles
Property, Plant and Equipment [Line Items]
Estimated Useful Lives (Years)	5 years
Property, plant, and equipment, gross	$ 527	161
Hardware and software
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 2,487	1,683
Hardware and software | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives (Years)	3 years
Hardware and software | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Lives (Years)	5 years
Assets in progress
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 3,684	$ 1,880

Property, Plant, and Equipmen_3

Property, Plant, and Equipment - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 0.7	$ 0.6	$ 1.8	$ 1.8
Depreciation allocated to cost of revenue	0.4	0.5	1.2	1.5
Depreciation included in depreciation and amortization	$ 0.3	$ 0.1	$ 0.6	$ 0.3

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Jan. 11, 2022	Dec. 31, 2021	Jul. 08, 2016
Goodwill [Line Items]
Goodwill	$ 359,629,000		$ 359,629,000			$ 69,727,000
Accumulated impairment	51,900,000		51,900,000
Acquisition of STI			335,359,000
Amortization expense related to intangible assets	23,200,000	$ 5,900,000	69,800,000	$ 17,600,000
Array Legacy Operations
Goodwill [Line Items]
Goodwill	69,727,000		69,727,000			69,727,000
Acquisition of STI			0
STI Operations
Goodwill [Line Items]
Goodwill	289,902,000		289,902,000			$ 0
Array Legacy Operations
Goodwill [Line Items]
Goodwill							$ 121,600,000
STI
Goodwill [Line Items]
Goodwill	$ 335,359,000		335,359,000		$ 327,748,000
Acquisition of STI			335,400,000
STI | STI Operations
Goodwill [Line Items]
Acquisition of STI			$ 335,359,000

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Schedule of Goodwill (Details)	9 Months Ended
	Sep. 30, 2022 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 69,727,000
Acquisition of STI	335,359,000
Foreign currency impact	(45,457,000)
Goodwill, ending balance	359,629,000
Array Legacy Operations
Goodwill [Roll Forward]
Goodwill, beginning balance	69,727,000
Acquisition of STI	0
Foreign currency impact	0
Goodwill, ending balance	69,727,000
STI Operations
Goodwill [Roll Forward]
Goodwill, beginning balance	0
Foreign currency impact	(45,457,000)
Goodwill, ending balance	289,902,000
STI
Goodwill [Roll Forward]
Acquisition of STI	335,400,000
Goodwill, ending balance	335,359,000
STI | STI Operations
Goodwill [Roll Forward]
Acquisition of STI	$ 335,359,000

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Schedule of Other Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	$ 567,855	$ 293,300
Finite-lived intangible assets, accumulated amortization	194,071	128,847
Total amortizable intangibles, net	373,784	164,453
Total other intangible assets, net	384,084	174,753
Trade name
Finite-Lived Intangible Assets [Line Items]
Non-amortizable costs:	$ 10,300	10,300
Developed technology
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, estimated useful lives (years)	14 years
Finite-lived intangible assets, gross	$ 203,800	203,800
Finite-lived intangible assets, accumulated amortization	$ 90,709	79,790
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, estimated useful lives (years)	10 years
Finite-lived intangible assets, gross	$ 295,405	89,500
Finite-lived intangible assets, accumulated amortization	$ 70,606	49,057
Backlog
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, estimated useful lives (years)	1 year
Finite-lived intangible assets, gross	$ 44,132	0
Finite-lived intangible assets, accumulated amortization	$ 31,794	0
Trade name
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible asset, estimated useful lives (years)	20 years
Indefinite-lived intangible assets, gross	$ 24,518	0
Indefinite-lived intangible assets, accumulated amortization	$ 962	$ 0

Goodwill and Other Intangible_6

Goodwill and Other Intangible Assets - Schedule of Future Annual Amortization Expense of Amortizable Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2022	$ 22,365
2023	46,633
2024	45,328
2025	45,328
2026	41,021
Thereafter	173,109
Total amortizable intangibles, net	$ 373,784	$ 164,453

Investment in Equity Security (

Investment in Equity Security (Details) - USD ($)	1 Months Ended		9 Months Ended
	Apr. 30, 2021	Feb. 28, 2021	Sep. 30, 2022	Sep. 30, 2021
Investments, Debt and Equity Securities [Abstract]
Investment in equity securities	$ 2,000,000	$ 10,000,000	$ 0	$ 11,975,000
Balance of investment in equity securities			12,000,000
Impairment recorded			$ 0

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Income tax expense (benefit)	$ 11,144,000	$ (5,361,000)	$ (18,109,000)	$ (5,493,000)
Legal settlement, tax expense	8,700,000		8,700,000
Reserves for uncertain tax positions	$ 0	$ 0	$ 0	$ 0

Senior Secured Credit Facilit_2

Senior Secured Credit Facility - Schedule of Long-Term Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Jan. 07, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Less discount and issuance costs		$ (1,300)
Less current portion of credit facility	$ (47,686)		$ (4,300)
Long-term senior secured facility debt, net of current portion, debt discount and issuance costs	725,109		711,056
Senior secured credit facility
Debt Instrument [Line Items]
Long-term debt, balance	323,550		326,775
Less discount and issuance costs	(20,169)		(23,291)
Long-term portion, net of debt discount and issuance costs	303,381		303,484
Less current portion of credit facility	(4,300)		(4,300)
Term loan facility | Senior secured credit facility
Debt Instrument [Line Items]
Long-term debt, balance	323,550		326,775
Revolving credit facility | Senior secured credit facility
Debt Instrument [Line Items]
Long-term debt, balance	0		0
Long-term senior secured facility debt, net of current portion, debt discount and issuance costs	$ 299,081		$ 299,184

Senior Secured Credit Facilit_3

Senior Secured Credit Facility - Narrative (Details) - USD ($)				9 Months Ended
	Feb. 23, 2021	Feb. 22, 2021	Oct. 14, 2020	Sep. 30, 2022	Jan. 07, 2022	Dec. 31, 2021	Feb. 26, 2021
Debt Instrument [Line Items]
Less: unamortized discount and issuance costs					$ 1,300,000
Term loan facility
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 575,000,000
Debt instrument term			7 years
Revolving Loan applicable margin	3.75%
Long-term debt, balance				$ 323,600,000		$ 326,800,000
Less: unamortized discount and issuance costs				$ 20,200,000		23,300,000
Debt issuance costs and discounts, amortization rate				6.75%
Term loan facility | Revolving Credit Facility, First Amendment
Debt Instrument [Line Items]
Revolving Loan applicable margin	5%
Revolving credit facility
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 150,000,000				$ 150,000,000
Debt instrument term			5 years
Long-term debt, balance				$ 0		0
Available borrowing capacity				$ 166,600,000		186,400,000
Revolving credit facility | Minimum
Debt Instrument [Line Items]
Revolving Loan applicable margin				1%
Revolving credit facility | Maximum
Debt Instrument [Line Items]
Revolving Loan applicable margin				2.25%
Revolving credit facility | Revolving Credit Facility, Second Amendment
Debt Instrument [Line Items]
Maximum borrowing capacity							$ 200,000,000
Revolving credit facility | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Revolving Loan applicable margin				3.25%
Revolving credit facility | Fed Funds Effective Rate Overnight Index Swap Rate
Debt Instrument [Line Items]
Revolving Loan applicable margin				1%
Senior secured credit facility | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Monthly basis spread on variable rate	0.50%	1%
Senior secured credit facility | Base Rate
Debt Instrument [Line Items]
Minimum annual variable rate	0.0325	0.0400
Standby letters of credit
Debt Instrument [Line Items]
Letters of credit outstanding				$ 33,400,000		$ 13,600,000

Convertible Debt - Summary of C

Convertible Debt - Summary of Convertible Debt (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Jan. 07, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Less: unamortized discount and issuance costs		$ 1,300
Effective interest rate	1%
Convertible Debt
Debt Instrument [Line Items]
1.00% Senior unsecured convertible notes	$ 425,000		$ 425,000
Less: unamortized discount and issuance costs	(11,721)		(13,137)
Long-term portion, net of debt discount and issuance costs	$ 413,279		$ 411,863
Effective interest rate	1.50%		1.50%

Convertible Debt - Narrative (D

Convertible Debt - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions				9 Months Ended
	Jan. 07, 2022	Dec. 09, 2021	Dec. 03, 2021	Sep. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Effective interest rate				1%
Common Stock
Debt Instrument [Line Items]
Debt issuance costs	$ 15.9
Convertible Note Capped Call Transactions
Debt Instrument [Line Items]
Debt conversion, converted instrument, shares issued (in shares)				17,800,000
Debt issuance costs				$ 52.9
Derivatives, cap price (in dollars per share)				$ 36.02
Derivatives, exercise price (in dollars per share)				$ 23.86
Convertible Debt
Debt Instrument [Line Items]
Effective interest rate				1.50%	1.50%
Convertible Debt | Convertible Senior Notes due 2028
Debt Instrument [Line Items]
Bridge loan facility aggregate principal amount		$ 50	$ 375
Effective interest rate		1%	1%
Proceeds from convertible debt		$ 48.6	$ 364.7
Debt instrument, interest rate, effective percentage discount		2.75%	2.75%
Debt instrument, annual interest rate				1%
Convertible Debt | Convertible Senior Notes due 2028 | Common Stock
Debt Instrument [Line Items]
Conversion of stock, shares converted per dollar (in shares)				41.9054
Convertible note, conversion price (in dollar per share)				$ 23.86
Debt conversion, converted instrument, shares issued (in shares)				10,100,000

Other Debt - Narrative (Details

Other Debt - Narrative (Details) - STI $ in Millions	Sep. 30, 2022 USD ($)
Debt Instrument [Line Items]
Short-term debt	$ 43.3
Long-term debt	12.7
Debt maturing in 2024	4.9
Debt maturing in 2027	$ 7.8
Minimum
Debt Instrument [Line Items]
Stated interest rate	0.55%
Maximum
Debt Instrument [Line Items]
Stated interest rate	2.76%

Redeemable Perpetual Preferre_2

Redeemable Perpetual Preferred Stock (Details)					3 Months Ended	9 Months Ended
	Jan. 07, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) shares	Sep. 27, 2021 USD ($) representative shares	Aug. 10, 2021 USD ($) shares	Sep. 30, 2022 USD ($) shares	Sep. 30, 2022 USD ($) shares	Sep. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Dec. 31, 2020 USD ($)
Temporary Equity [Line Items]
Temporary equity, shares issued (in shares) | shares		350,000			400,000	400,000
Stock issued (in shares) | shares	1,125,000
Net proceeds from sale of series A perpetual preferred stock	$ 49,400,000
Temporary equity, liquidation preference		$ 350,000,000			$ 400,000,000	$ 400,000,000
Issuance of common stock, net (in shares) | shares	50,000
Temporary equity, carrying amount, attributable to parent		237,462,000			287,561,000	287,561,000	$ 235,278,000	$ 293,974,000	$ 0	$ 0
Common stock, value, issued		135,000			150,000	150,000
Stockholders' equity		(69,205,000)			61,817,000	61,817,000	1,464,000	$ 63,853,000	$ (72,420,000)	$ (80,899,000)
Less: unamortized discount and issuance costs	$ 1,300,000
Percentage of variable weighted average price of temporary equity	95%
Temporary equity, permitted accrued dividends					0	0
Dividends paid					$ 18,670,000	18,670,000
Distributed earnings		$ 8,200,000
Temporary equity, amortization of discount, period	5 years
Payments of dividends						$ 18,670,000	$ 0
Anniversary Date One
Temporary Equity [Line Items]
Purchase commitment, percentage	0%
Anniversary Date Two
Temporary Equity [Line Items]
Purchase commitment, percentage	1.50%
Anniversary Date Three
Temporary Equity [Line Items]
Purchase commitment, percentage	3%
Securities Purchase Agreement
Temporary Equity [Line Items]
Net proceeds from sale of series A perpetual preferred stock				$ 346,000,000
Repayment of long term line of credit			$ 100,000,000
Proceeds from Series A issuance	$ 334,600,000
Temporary equity, carrying amount, attributable to parent	229,800,000
Common stock, value, issued	105,400,000
Stockholders' equity	12,400,000
Derivative instrument, prepaid forward contract	11,700,000
Securities Purchase Agreement, Voting and Consent Rights
Temporary Equity [Line Items]
Number of members eligible to be designated to board of directors | representative			1
Number of non-voting representatives designated to board of directors | representative			3
Securities Purchase Agreement, Additional Closings
Temporary Equity [Line Items]
Net proceeds from sale of series A perpetual preferred stock				$ 148,000,000
Series A Redeemable Perpetual Preferred Stock
Temporary Equity [Line Items]
Temporary equity, shares issued (in shares) | shares					13	13
Debt issuance costs	$ 33,100,000
Initial liquidation preference (in dollars per share) | $ / shares	$ 1,000
Temporary equity, amortization of discount	$ 120,200,000
Temporary equity, accretion of interest						$ 17,200,000
Payments of dividends					$ 6,300,000
Dividend rate, percentage					5.75%
Series A Redeemable Perpetual Preferred Stock | Accrued Regular Dividend Rate
Temporary Equity [Line Items]
Dividend rate, percentage	6.25%
Series A Redeemable Perpetual Preferred Stock | Cash Regular Dividend Rate
Temporary Equity [Line Items]
Dividend rate, percentage	5.75%
Temporary equity dividend rate spread	2%
Percent of the amount of default accrued dividends to be paid	100%
Series A Redeemable Perpetual Preferred Stock | Cash Regular Dividend Rate | Fifth, Sixth, and Seventh Anniversaries
Temporary Equity [Line Items]
Temporary equity dividend rate spread	0.50%
Series A Redeemable Perpetual Preferred Stock | Cash Regular Dividend Rate | Eighth, Ninth, and Tenth Anniversaries
Temporary Equity [Line Items]
Temporary equity dividend rate spread	1%
Series A Redeemable Perpetual Preferred Stock | Securities Purchase Agreement
Temporary Equity [Line Items]
Temporary equity, shares issued (in shares) | shares				350,000
Repayment of long term line of credit			$ 102,000,000
Temporary equity, liquidation preference			$ 100,000,000
Series A Redeemable Perpetual Preferred Stock | Securities Purchase Agreement, Additional Closings
Temporary Equity [Line Items]
Stock issued (in shares) | shares				150,000
Common Stock
Temporary Equity [Line Items]
Debt issuance costs	$ 15,900,000
Common Stock | Securities Purchase Agreement
Temporary Equity [Line Items]
Stock issued (in shares) | shares				7,098,765
Common Stock | Securities Purchase Agreement, Expiry or Termination | BCP Helios Aggregator L.P.
Temporary Equity [Line Items]
Stock issued (in shares) | shares			776,235
Net proceeds from sale of series A perpetual preferred stock			$ 776
Common Stock | Securities Purchase Agreement, Additional Closings
Temporary Equity [Line Items]
Stock issued (in shares) | shares				3,375,000
Common Stock | Securities Purchase Agreement, Additional Closings, Certain Pricing Adjustments
Temporary Equity [Line Items]
Stock issued (in shares) | shares				6,100,000

Revenue (Details)

Revenue (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 515,024,000	$ 188,686,000	$ 1,235,475,000	$ 633,442,000
Unbilled receivables	136,953,000		136,953,000		$ 111,224,000
Deferred revenue	154,692,000		154,692,000		$ 99,575,000
Deferred revenue recognized			$ 73,100,000
Percentage of deferred revenue recognized			73%
Remaining performance obligation	$ 386,300,000		$ 386,300,000
Percentage of performance obligation to be recognized	100%		100%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01
Disaggregation of Revenue [Line Items]
Remaining performance obligation, period	12 months		12 months
Bill-and-hold Obligations
Disaggregation of Revenue [Line Items]
Revenue	$ 0		$ 0
Over-time revenue
Disaggregation of Revenue [Line Items]
Revenue	458,405,000	128,183,000	991,561,000	360,581,000
Over-time revenue | Revision of Prior Period, Adjustment
Disaggregation of Revenue [Line Items]
Revenue				(223,200,000)
Point in time revenue
Disaggregation of Revenue [Line Items]
Revenue	$ 56,619,000	$ 60,503,000	$ 243,914,000	272,861,000
Point in time revenue | Revision of Prior Period, Adjustment
Disaggregation of Revenue [Line Items]
Revenue				$ 223,200,000

Income (Loss) Per Share - Sched

Income (Loss) Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share [Abstract]
Net income (loss)	$ 40,822	$ (27,561)	$ 13,542	$ (28,502)
Preferred dividends and accretion	12,257	5,479	36,045	5,479
Net income (loss) to common shareholders	$ 28,565	$ (33,040)	$ (22,503)	$ (33,981)
Basic:
Weighted-average shares (in shares)	150,322	130,955	149,604	128,315
Income (loss) per share (in dollars per share)	$ 0.19	$ (0.25)	$ (0.15)	$ (0.26)
Diluted:
Effect of restricted stock and performance awards (in shares)	1,060	0	0	0
Weighted average shares (in shares)	151,382	130,955	149,604	128,315
Income (loss) per share (in dollars per share)	$ 0.19	$ (0.25)	$ (0.15)	$ (0.26)

Income (Loss) Per Share - Narra

Income (Loss) Per Share - Narrative (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share [Abstract]
Equity compensation anti-dilutive securities (in shares)	108,111	1,203,520	2,504,046	1,203,520

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands		9 Months Ended
	Jul. 15, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020
Surety Bond
Business Acquisition, Contingent Consideration [Line Items]
Contractual obligation		$ 175,200
Array Legacy Operations | Tax Receivable Agreement
Business Acquisition, Contingent Consideration [Line Items]
Contingent consideration		$ 7,113	$ 7,686	$ 14,577	$ 12,952	$ 12,016	$ 19,691
Tax Receivable Agreement, payment term		125 days
Nextracker Litigation | Settled Litigation
Business Acquisition, Contingent Consideration [Line Items]
Loss contingency, damages awarded, value	$ 42,800

Commitments and Contingencies_2

Commitments and Contingencies - Summary of Liability Related To Estimated Contingent Consideration (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Business Combination, Contingent Consideration Arrangements, Change In Amount Of Contingent Consideration [Roll Forward]
Payments			$ (1,483)	$ (7,810)
Fair value adjustment	$ (572)	$ 936	(5,981)	1,071
Array Legacy Operations | Tax Receivable Agreement
Business Combination, Contingent Consideration Arrangements, Change In Amount Of Contingent Consideration [Roll Forward]
Beginning balance	7,686	12,016	14,577	19,691
Payments	0	0	(1,483)	(7,810)
Fair value adjustment	(573)	936	(5,981)	1,071
Ending balance	$ 7,113	$ 12,952	$ 7,113	$ 12,952

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Schedule of carrying values and estimated fair values of debt instruments (Details) - Convertible Debt - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
1.00% Senior unsecured convertible notes, net	$ 413,279	$ 411,863
Convertible senior notes, fair value	$ 381,625	$ 410,771

Equity-Based Compensation - Nar

Equity-Based Compensation - Narrative (Details) - USD ($) $ in Millions				3 Months Ended		9 Months Ended
	May 19, 2020	Mar. 28, 2020	Nov. 19, 2019	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Oct. 14, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility rate minimum						66%
Expected volatility rate maximum						79%
Risk free interest rate minimum						0.28%
Risk free interest rate maximum						2.79%
Forfeitures in period (in shares)				76,936	18,772	196,003	79,277
Class B units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity based compensation							$ 8.9
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted in period (in shares)						1,433,829
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted in period (in shares)						466,916
Vesting period						3 years
Equity grants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity based compensation				$ 4.2	$ 2.2	$ 11.7	$ 14.3
Equity grants | Class B units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted in period (in shares)	4,344,941		22,326,653
Unrecognized compensation costs				$ 23		$ 23
Unrecognized compensation costs, period of recognition						2 years
Equity grants | Class C Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted in period (in shares)		1,000
2020 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Authorized shares (in shares)								6,683,919

Equity-Based Compensation - Sch

Equity-Based Compensation - Schedule of RSU Activity (Details)	9 Months Ended
	Sep. 30, 2022 $ / shares shares
RSUs
Number of Shares
Unvested, beginning balance (in shares) | shares	930,409
Granted (in shares) | shares	1,433,829
Vested (in shares) | shares	(278,792)
Forfeited (in shares) | shares	(127,325)
Unvested, ending balance (in shares) | shares	1,958,121
Weighted Average Grant Date Fair Value
Unvested, weighted average grant date fair value, beginning balance (in dollars per share) | $ / shares	$ 21.66
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	10.16
Vested, weighted average grant date fair value (in dollars per share) | $ / shares	18.68
Forfeited, weighted average grant date fair value (in dollars per share) | $ / shares	18.50
Unvested, weighted average grant date fair value, ending balance (in dollars per share) | $ / shares	$ 13.97
PSUs
Number of Shares
Unvested, beginning balance (in shares) | shares	147,687
Granted (in shares) | shares	466,916
Vested (in shares) | shares	0
Forfeited (in shares) | shares	(68,678)
Unvested, ending balance (in shares) | shares	545,925
Weighted Average Grant Date Fair Value
Unvested, weighted average grant date fair value, beginning balance (in dollars per share) | $ / shares	$ 27.75
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	10.88
Vested, weighted average grant date fair value (in dollars per share) | $ / shares	0
Forfeited, weighted average grant date fair value (in dollars per share) | $ / shares	30.74
Unvested, weighted average grant date fair value, ending balance (in dollars per share) | $ / shares	$ 12.95

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Related Party Transactions [Abstract]
Accounts payable - related party	$ 478	$ 610

Segment Reporting - Narrative (

Segment Reporting - Narrative (Details) - segment	9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021
Segment Reporting [Abstract]
Number of operating segments	2	2	1

Segment Reporting - Schedule of

Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Revenue	$ 515,024	$ 188,686	$ 1,235,475	$ 633,442
Gross Profit	80,223	5,897	146,756	72,570
Array Legacy Operations
Segment Reporting Information [Line Items]
Revenue	400,463	188,686	998,292	633,442
Gross Profit	63,921	$ 5,897	119,029	$ 72,570
STI Operations
Segment Reporting Information [Line Items]
Revenue	114,561		237,183
Gross Profit	$ 16,302		$ 27,727